Pet Supplement Brand Transparency Report 2026
Nov 15, 2026: Plano Paws label/accessibility and Pawfy expert-role corrections; other criterion dates retained.
56 ranked competitors · publisher benchmark shown separately
What changed
Nov 15, 2026: Plano Paws label/accessibility and Pawfy expert-role corrections; other criterion dates retained.
Median of the 56 ranked records: 68.25/100. These aggregates describe this publication’s dated records, not a new audit of the whole market.
Nutramax Laboratories
74.5/100 under the published rubric.
Nutramax scores 74.5/100 under the existing public-disclosure rubric. The reviewed core product families publish substantial label and manufacturing information, named veterinary leadership and specific testing processes. Public research exists; citation placement and batch-result access remain less complete.
Criterion scores and reasons
| Criterion | Score | Weight | Evidence and limits |
|---|---|---|---|
| label dose transparency | 8/10 | 15 | The sampled Cosequin MSM tablet, Dasuquin MSM soft chews, Denamarin chewable tablet and Welactin Advanced 3TA liquid publish named active amounts and serving directions. Proviable-DC identifies seven strains but guarantees their combined CFU count. Dasuquin Senior provides individual core amounts and a separately named three-ingredient blend total. This is a five-family representative sample with Senior as a variation check, not a census of every Nutramax SKU. ASU values are standardized powder amounts; EPA+DHA totals are not separate EPA/DHA amounts. |
| scientific rationale disclosure | 7/10 | 10 | Denamarin explains SAMe, glutathione and silybin with references; Dasuquin explains cartilage roles and its ingredient combination; Proviable explains the different roles of probiotics and prebiotics. Explanations on the sampled Cosequin and Welactin pages are shorter and predominantly benefit-oriented. The score describes the consistency of public explanations, not whether the ingredients work or every mechanism is clinically established at the supplied dose. |
| evidence clinical citation transparency | 6/10 | 15 | Denamarin publishes author/journal references linked to public records. The reviewed Proviable and Dasuquin product pages use research language without consistently placing full study identification next to the claim. Public journal papers on Proviable-DC and Dasuquin with MSM are accessible outside the professional portal. Those papers do not establish every claim, all six advertised Proviable studies, all current formulas or Dasuquin Senior outcomes. External discoverability corrects the old all-evidence-gated implication; it does not automatically turn every product page into a well-cited page. |
| veterinary expert transparency | 8/10 | 15 | Public Nutramax news materials name Todd Henderson, DVM, as President and CEO. The quality-audit announcement also names Godwin Omorogieva as Vice President of Quality. These identify people and their disclosed company roles, although they are found in media material rather than a consolidated expert page. Executive leadership is the role verified for Henderson; it is not proof he formulated or reviewed each product. Omorogieva is named with a role, but no professional credential is inferred. |
| testing coa transparency | 7/10 | 15 | The public quality process distinguishes raw-material analytical chemistry and microbiology, internal raw-material COAs, in-process checks, finished-product testing in Nutramax chemistry/microbiology laboratories and stability testing. These are specific testing disclosures. The reviewed quality, product and media sources do not provide a purchaser-facing finished-product lot-to-COA lookup or an enumerated contaminant panel with batch results. This finite finding does not establish that testing or COAs do not exist. A facility auditor is not treated as the product-testing laboratory. |
| manufacturing quality system transparency | 9/10 | 10 | Nutramax identifies owned manufacturing in Lancaster, South Carolina; product contact information supplies the Quality Drive address. Its primary-navigation quality page explains supplier approval, incoming-material checks, cGMP/SOPs and production controls. The May 26, 2022 announcement identifies a UL-administered independent GMP conformance assessment. The reviewed public sources do not supply current audit scope or renewal details, or complete ingredient-origin traceability. The 2022 announcement is historical disclosure; this does not establish that current certification or sourcing records are absent. |
| claim discipline consumer honesty | 8/10 | 10 | The sampled product pages primarily use support language and attach survey attribution to veterinarian-recommendation statements. Some research/combination wording is more categorical than the study identification supplied beside it, particularly on Dasuquin and Proviable. This is a sampled disclosure assessment. Survey raw data, every historical advertisement and the clinical substantiation for every support claim were not audited. A study-access gap is not a finding that the advertised benefit is false. |
| accessibility buyer verifiability | 7/10 | 10 | Quality and manufacturing explanations are linked from corporate navigation. Product facts and some references are public across the product domains. Named leadership appears in media material, and additional research is accessible through public journals. Finding the whole record requires moving between product domains, media pages and journal sources; it is not all assembled in a single buyer evidence hub. Professional access is not the only route to all studies. |
Sources reviewed through 11 November 2026. Representative US product-family sample: Cosequin US chewable tablets with MSM; Dasuquin US With MSM soft chews, both size formulas; Denamarin US chewable tablets for dogs; Proviable US DC capsules; Welactin US Advanced3TA liquid for dogs,2mL scoop. Dasuquin Senior checked separately for variation. This is not a census of every SKU.
n-cosequin; n-dasuquin; n-dasuquin-about; n-dasuquin-trial; n-denamarin-about; n-denamarin-label; n-media; n-proviable-label; n-proviable-study; n-quality; n-senior; n-story; n-ul; n-welactin
Wholistic Pet Organics
68.5/100 under the published rubric.
68.5/100 under the existing brand-disclosure rubric. Quantified labels, public quality systems and accessible company information earn substantial credit; citation presentation, role specificity and mixed dose formats leave defined gaps.
Criterion scores and reasons
| Criterion | Score | Weight | Evidence and limits |
|---|---|---|---|
| label dose transparency | 6/10 | 15 | The eight-product sample has substantial quantities, with recurring grouped blends and mixed analysis/serving bases. Meaningful disclosure earns credit; whole-food nutrient concentrations are not every ingredient’s input weight. |
| scientific rationale disclosure | 8/10 | 10 | Ingredient roles are explained across nutrition, joint, digestive, immune and oil products; some explanations remain benefit-led. Recognized nutrient/enzyme roles receive credit without requiring a new finished-product trial. |
| evidence clinical citation transparency | 4/10 | 15 | Run Free uses therapeutic-style ingredient explanations; the food/supplement page invokes study levels without identifiable study citations. This scores citation presentation in reviewed sources, not whether research exists elsewhere. |
| veterinary expert transparency | 6/10 | 15 | The family mission identifies relevant founder education and development history, but current scientific roles need interpretation. No requirement for a separate named formulator for every product is imposed. |
| testing coa transparency | 7/10 | 15 | A risk-based third-party testing program and release controls are described; public lot-report access remains limited. NASC audit is credited separately and not recast as a product laboratory report. |
| manufacturing quality system transparency | 10/10 | 10 | Own Bedford manufacturing, quality programs, supplier controls and lot traceability are reachable through primary navigation. Full credit is for disclosure; it does not independently certify each registration or operational claim. |
| claim discipline consumer honesty | 7/10 | 10 | Normal-support positioning coexists with broad nutrition and therapeutic-style benefit language whose supporting evidence is not surfaced. This is a qualified presentation judgment, not a finding of deception or product ineffectiveness. |
| accessibility buyer verifiability | 9/10 | 10 | Quality and family history are accessible through Why Wholistic; ingredient rationale is accessible through product navigation. The evidence is distributed across primary links rather than consolidated into one complete evidence hub. |
Sources reviewed through 11 November 2026. Representative sample of eight products: Canine Complete, Feline Complete, Joint Mobility, Run Free, Digest-All, Total Immune, multivitamin soft chews and Salmon Oil. Purposeful representative public-product sample, not best-disclosed-SKU selection: foundational dog/cat powders, broad and concentrated joint powders, digestive powder, immune powder, multi soft chew and omega oil.
w-canine; w-feline; w-joint; w-runfree; w-immune; w-chew; w-digest; w-salmon; w-quality; w-nasc; w-mission; w-why; w-food
Symbol key How to read the badges and watchouts Brand signals · watchouts
Each ranking row earns badges for what the brand publishes well, and may carry up to three Worth Noting watchouts for limitations buyers should be aware of. The same rules apply to every brand on this page, including La Petite Labs.
Breadth, disclosure, and substantiation.
- Brands score high when buyers can independently verify the formula, science, named experts, testing, and claims — without emailing support or trusting marketing language.
- Per-active milligram amounts disclosed on the public label.
- Named third-party lab, published Certificate of Analysis, lot-level traceability.
- Public substantiation for marketing claims — citations, not adjectives.
Narrower scope, or less of the work published.
- Brands score lower when evidence is missing, hidden behind support contact, or substituted with vague language ("clinically tested," "veterinarian-formulated," "third-party verified") that cannot be checked.
- Actives are listed without per-serving amounts (proprietary blends).
- Testing language is vague — no named lab, no public COA, no lot linkage.
- Claims outrun the public evidence record at time of review.
A lower score does not automatically mean a product is unsuitable. It may simply be narrower in scope, less transparent, or supported by fewer public quality signals than this rubric rewards.
Every number below is a public transparency score: what a buyer can verify from public materials before purchase — not effectiveness, safety, ingredient quality, or customer satisfaction. Read the full methodology.
No brands match
Try a brand name, manufacturer, or partial term — or .
1Rank87/100as of 2026-06-13Strong1Rank
ElleVet Sciences
ElleVet Sciences
South Portland, Maine, United States87/100as of 2026-06-13StrongElleVet Sciences sits well above the category median on research and expert disclosure: it cites peer-reviewed finished-formula trials with authors and journals, names a credentialed CMO and Advisory Board from primary navigation, and runs a public lot-linked COA lookup with a named lab. The gaps are in label granularity (cannabinoids grouped as a proprietary CBD + CBDA total), COA panel scope (potency-only on the surfaced certificate), and facility-level manufacturing identity, which stays at region and corporate-HQ level.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreePublic COA LookupPer-Lot TraceabilityNASC Member Finished-Formula Trial Named Mfg FacilityWhat's in it
- Publishes a research library of clinical, safety and pharmacokinetic studies on its CBD + CBDA formulations with direct publication links; the current overview reports over 23 peer-reviewed publications.
- Surfaces a fully named Chief Medical Officer (Dr. Joseph Wakshlag, DVM, PhD, DACVIM, DACVSMR) and a deep Advisory Board of board-certified diplomates with detailed bios, reachable from primary navigation.
- Operates a public, self-serve, lot-linked COA lookup with the third-party lab (ProVerde) named, and publishes detailed receptor-level ingredient mechanism content on its Science page.
What's not in it
- Cannabinoid actives are disclosed as a combined CBD + CBDA total under a proprietary complete-spectrum label across the line, with minor cannabinoids and terpenes unquantified per serving.
- The publicly pullable COA shows cannabinoid potency only; the heavy-metal, pesticide, and microbial panels described in the FAQ are not surfaced on the lot certificate.
- The FAQ states GMP-certified manufacture and NASC membership, but does not identify the manufacturing facility or the GMP certifier.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsEvery reviewed PDP publishes a per-serving active panel with defined serving sizes and a full alphabetical inactive-ingredient list. The Soft Chews disclose Glucosamine (Shellfish) 340mg / 510mg and Chondroitin (Bovine) 140mg / 210mg per small and large chew respectively, and all cannabinoid SKUs state a combined CBD + CBDA milligram figure: oil at 70mg/mL, soft gels at 3.8mg / 11.3mg / 28mg / 37.5mg per size, and Calm & Comfort at 46mg per 6g chew. The limiting pattern is line-wide rather than SKU-specific: the cannabinoid actives are presented as a proprietary complete-spectrum total ('ElleVet Complete Spectrum Proprietary Hemp Oil 20mg (contains 12.8mg of CBD + CBDA and other minor cannabinoids)') rather than itemizing CBD and CBDA separately, and the minor cannabinoids and terpenes are never quantified per serving on the label. The example COA for lot R9005-14 does break the blend into CBD 34.565 and CBDA 33.033 mg/mL, so the split is verifiable at the batch level even though it is grouped on the panel. Disclosure is therefore strong and consistent on the primary actives but relies on a grouped, proprietary-blend figure for the cannabinoid component across the whole line.The score is held below 8 because the cannabinoid actives are disclosed as a combined CBD + CBDA total under a proprietary complete-spectrum label across every SKU, and the minor cannabinoids and terpenes are unquantified per serving. Itemizing CBD and CBDA separately on the panel and publishing per-serving amounts for the minor cannabinoids and terpenes (rather than 'and other minor cannabinoids') would lift it toward 9-10.Soft Chews contain our proprietary oil formulation, as well as glucosamine and chondroitin.The /cbd-science/ page is an unusually deep ingredient-rationale resource for the category. It explains the endocannabinoid system and then names the specific receptor systems ElleVet attributes the response to, walking through TRP channels, GPR55, PPAR-g, the 5HT1A and 5HT3A serotonin receptors, the glycine receptor, and adenosine transport, and explicitly argues the CB1/CB2 receptors are not the operative mechanism at achievable serum concentrations. It separates the biological roles of CBDA versus CBD (CBDA absorption and serotonin/anti-inflammatory effect), describes FAAH enzyme inhibition, and gives terpene-by-terpene rationale (myrcene, limonene, alpha-pinene, beta-caryophyllene, humulene, linalool) plus the entourage effect. The glucosamine and chondroitin in the chews appear as named label actives without a comparable mechanism or benefit explanation on the reviewed pages. Because the cannabinoid blend is the core active across the entire line and its mechanism is documented exhaustively with supporting research cited on the same page, rationale coverage is near-complete.The score sits at 9 rather than 10 because the secondary joint actives (glucosamine, chondroitin) are surfaced as label ingredients without a mechanism explanation, and mechanism content is concentrated on the central Science page rather than restated per product. Adding ingredient-level mechanism and citations for glucosamine and chondroitin would complete the criterion.ElleVet’s research has shown that it is far more complex and that the receptors involved include the TRP, GPR, PPAR-g GPR55, 5HT, glycine, and adenosine uptake receptors.The current library links clinical, safety and pharmacokinetic studies on ElleVet CBD+CBDA formulations. Its overview reports over 23 peer-reviewed publications and more than 40 clinical studies; those are program totals, not a finished-formula RCT count.The criterion's 10 anchor is met. The only residual nuance is that several of the more recent reports (Calm & Comfort, dental stick, equine pellets, feline urinary) are white papers hosted on the ElleVet domain rather than peer-reviewed journal articles; labeling each report's peer-review status inline would remove any ambiguity between published trials and self-hosted white papers.Dogs were randomly assigned to receive either 2 mg/kg of an equal mix of CBD/CBDA rich hemp from ElleVet Sciences (n = 17) or placebo for four weeks.Named expert disclosure is comprehensive and reachable from primary navigation (About > Meet the Team). Dr. Joseph Wakshlag is surfaced as Chief Medical Officer and Chair of the Advisory Board with full credentials (DVM, PhD, DACVIM Nutrition, DACVSMR, Professor at Cornell) and a documented role and scope: he conducted the first ElleVet clinical trial and the first pharmacokinetic and safety studies. Beyond him, a full Advisory Board of board-certified diplomates is listed with detailed bios, including specialists across surgery and sports medicine (Adair, Kaneps), behavior (Albright), dermatology (Santoro, whose specialty maps to the published skin trial), internal medicine and cardiology (Ettinger, Kornreich), orthopedics and osteoarthritis (Kirkby Shaw), neurology (Wininger), pharmacovigilance (Elam, also ElleVet's Director of Pharmacovigilance), and regulatory science (McChesney, a former FDA CVM compliance director). Two staff veterinarians, Dr. Robert Menardi (Senior Director of Veterinary Education) and Dr. David Tittle (International Scientific Advisory Board), have dedicated bio pages with credentials and scope.The 10 anchor is met. A minor refinement would be to name a single lead formulator for the finished products; the formulation is attributed to the founders working with biochemists and to Dr. Wakshlag's research rather than to one named formulator, though the CMO and advisory disclosure more than satisfy the criterion.Dr. Wakshlag conducted the first ever clinical trial on dogs using ElleVet CBD + CBDA and continues to lead the way in hemp research.ElleVet operates a genuine public, self-serve, lot-linked COA program. The COA library explains where the batch number is printed on each SKU and provides a search field ('enter batch number here') that returns the matching certificate, and a live example for lot R9005-14 confirms lot-level traceability with a full cannabinoid potency panel (CBD 34.565, CBDA 33.033, D9-THC 1.837 mg/mL, total cannabinoids 75.367). The third-party laboratory is named: ProVerde. The FAQ additionally describes a multi-stage third-party testing program in which the extract is tested for contaminants and final batches are tested for potency. The limiter is panel scope on the surfaced certificate: the COA a buyer can actually pull is potency/cannabinoid-only and does not display the heavy-metal, pesticide, microbial, or residual-solvent results that the FAQ says are tested upstream.The score is held at 9 because the publicly accessible COA surfaces cannabinoid potency only; the contaminant and microbial panels are described in FAQ prose but their results are not shown on the lot certificate. Publishing the heavy-metal, pesticide, microbial, and residual-solvent results on each lot's COA would complete the 10 anchor.Proverde, the 3rd party lab that tests our products, does not test for CBCa, which accounts for 2-3% of our profile.ElleVet’s FAQ states GMP-certified manufacture and NASC membership. It does not name the manufacturing facility or GMP certifier.Facility identity and certifier are not given in the reviewed FAQ; GMP disclosure is present.Our products are made in a Good Manufacturing Practice (GMP) certified facility.ElleVet's claims are unusually well supported relative to the category, yet the framing runs confident. The home hero carries an unqualified 'Scientifically Proven' badge and product pages use 'proven' language ('Our proprietary CBD + CBDA has been proven to help decrease joint discomfort'), while the broader marketing leans on superlatives such as being 'the only product proven effective in multiple clinical trials.' These claims do trace to real published finished-formula trials, the site consistently carries the FDA structure/function disclaimer ('not intended to diagnose, treat, cure or prevent any disease'), review modules state results 'are not guaranteed, are not medically substantiated', and the home page qualifies its vet-endorsement claim with a footnote naming the Cornell double-blind study. The brand avoids overt disease-cure language. The remaining tension is that the strong 'proven' framing appears above the fold with the supporting citation living a click away on the Science page rather than inline; the per-benefit support claims are more cautiously worded (the home page frames the neurological benefit as 'CBD + CBDA can support healthy brain function'), so the headline 'Scientifically Proven' badge and the comparative 'only product proven' superlatives carry the confident framing without an inline citation.The score is held at 8 because confident 'proven'/'Scientifically Proven' framing appears above the fold without an inline citation or qualifier, and the comparative 'only product proven' superlatives sit a click away from their supporting studies rather than beside the claim. Moving the specific study citation inline beside each 'proven' claim and superlative would lift it toward 9-10.Our proprietary CBD + CBDA has been proven to help decrease joint discomfort and improve overall mobility, allowing your dog to get back to doing what they love.Three of the four evidence pillars are reachable with little effort. The Science (mechanism and study list) lives on a top-level 'Science' nav item, and named experts are one level down under About > Meet the Team, both in the primary header. Testing is reachable through the footer 'Certificate of Analysis' link, which opens a working self-serve batch lookup. The weaker pillar is manufacturing and sourcing: there is no dedicated manufacturing, quality, or sourcing page (those URLs 404), so a buyer must dig into the FAQ to find the Colorado-growing and farm-to-end-user disclosures. Evidence is also split between header and footer rather than gathered into a single consolidated trust hub, and the research list and COA library are footer-only.The score is held at 8 because the COA library and research list are footer-only, manufacturing/sourcing detail is buried inside the FAQ with no dedicated page, and there is no single consolidated 'Evidence & Trust' hub. Promoting testing and sourcing into primary navigation or a consolidated trust hub would lift it toward 9-10.First, you will need to find the batch number specific to your product.GMP/research details corrected November 14, 2026; criterion values unchangedSources: 16 sources reviewedIn-depth ElleVet Sciences review →1
ElleVet SciencesElleVet SciencesElleVet Sciences sits well above the category median on research and expert disclosure: it cites peer-reviewed finished-formula trials with authors and journals, names a credent...- 2RankFP
Fera Pets
Fera Pet Organics
United States80.0/100as of 2026-05-23StrongFera Pets presents above the DTC median on named-expert disclosure and operates a real lot-linked COA lookup. The brand publishes mechanism content with ingredient-level citations and avoids disease-treatment claim language. Substance gaps cluster on the legacy product line — flagship chewables disclose every active dose while powders and toppers fall back to total-blend amounts — and on facility-level manufacturing identity, which is held at country and certification-body level only.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreePublic COA LookupPer-Lot TraceabilityNASC Member Finished-Formula Trial Named Mfg FacilityWhat's in it
- Fully named five-member Vet Advisory Board with two ACVIM/ACVD board-certified diplomates and disclosed credentials — one of the stronger named-expert disclosures in the DTC pet supplement universe.
- Functional lot-linked COA lookup tool accepting LOT numbers or product names — real buyer-usable testing transparency rather than a placeholder badge.
- Brand-level Ingredients encyclopedia publishes per-ingredient mechanism content with linked peer-reviewed studies for most meaningful actives, including ashwagandha, milk thistle, glucosamine, and probiotic strains.
What's not in it
- Label transparency varies materially across the line: chewable SKUs disclose every active in mg / IU / CFU while legacy powders (Probiotic Supplement, Mushroom Blend, Whole Food Multivitamin Topper) use total-blend amounts or generic descriptors.
- Manufacturing facility is not named at facility / city / state level — only 'manufactured in the USA in an FDA-registered GMP facility, NASC certified' country-level disclosure.
- COA panel scope (which contaminants, microbials, potency assays) is not surfaced on the public Sustainability hub; third-party lab (Eurofins) is named only on the Fish Oil PDP rather than consistently across the line.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsDisclosure tier varies materially across the line. The chewable and liquid SKUs reviewed (Hip + Joint Support, Multivitamin Soft Chews, Wellness Blend for Cats, Fish Oil for Dogs) publish full per-active mg/IU/CFU panels with inactives, serving sizes, and (in Wellness Blend and Multivitamin Chews) strain-level probiotic identifiers. The legacy powder SKUs are weaker: USDA Organic Probiotic Supplement names 12 species at genus/species level only with a total CFU rather than per-strain CFU; USDA Organic Mushroom Blend discloses a 500 mg total blend across ten mushroom species without per-species mg amounts; Whole Food Multivitamin Topper lists key ingredients with mechanism descriptors but no per-active doses. Brand uses 'proprietary blend' marketing language on Hip + Joint despite the active panel being fully numerically disclosed — verbal friction without actual obfuscation. Modal-product score reflects the dispersion: the flagship chewables clear an 8, but powders and toppers do not.Legacy powder SKUs (Probiotic Supplement, Mushroom Blend, Whole Food Multivitamin Topper) do not publish per-active amounts at the disclosure tier the chewable SKUs achieve. Strain-level CFU is named on Wellness Blend and Multivitamin Chews but not on the flagship Probiotic Supplement.Our Mushroom Blend has anywhere between >16-50% Beta Glucans. It changes between batches due to variations in mushrooms.The brand-level Ingredients encyclopedia publishes per-ingredient mechanism content — biological role, plausible action, and selection rationale — for the majority of meaningful actives in the line. PDPs reinforce mechanism framing at the product level (turmeric, glucosamine, MSM, postbiotic action, lysine/taurine roles). The Ingredients page filters by both product and benefit category, which is a buyer-usable structure rather than a marketing-copy dump. Where it falls short of a 9 is uniformity: legacy SKUs (Mushroom Blend) describe ingredients in benefit terms more than mechanism terms, and the Whole Food Multivitamin Topper's mechanism content is single-sentence per ingredient. The brand does not publish a unifying scientific framework or finished-formula design rationale separate from per-ingredient logic.No brand-level scientific framework explaining finished-formula design (versus per-ingredient mechanism). Mechanism content is uneven across the line — strong on flagship chewables, thinner on legacy powders.Silymarin is a powerful antioxidant that supports normal inflammatory response.Citation discipline is present and uneven. Hip + Joint cites four studies including a peer-reviewed glucosamine/chondroitin review; Multivitamin Soft Chews link a randomized double-blind glucosamine/chondroitin trial AND a Bacillus subtilis DE-CA9 study; Wellness Blend for Cats links three peer-reviewed papers (green-lipped mussel, cranberry, taurine); the Ingredients hub links additional studies (ashwagandha, milk thistle, etc.). All cited research is ingredient-level rather than finished-formula. The brand uses 'clinically studied probiotic' for the named strain (DE-CA9) — which is defensible because the strain itself has a published trial — but does not separately publish a finished-formula clinical study. The brand also avoids 'clinically proven' language at the product level, which is the right call given the actual evidence inventory. The flagship USDA Organic Probiotic Supplement is the weak point: 12 species listed without strain identifiers means the linked prebiotic studies do not function as evidence for the probiotic claim.No finished-formula clinical trial published or referenced. Citation depth varies — flagship chewables carry multiple studies; the legacy probiotic SKU carries only prebiotic-component studies without strain-level probiotic evidence.Bacillus subtilis DE-CA9 effect on fecal scores and serum oxidative markers in healthy dogs.Five named veterinarians are surfaced with credentials, photographs, and biographical detail on a dedicated Vet Advisory Board page reachable from the footer and the mega-menu. Two of the five hold ACVIM or ACVD board specialty diplomate status — a substantive tier above the generic 'our vet team' framing that defines most DTC competitors. The founder Dr. Michelle Dulake (DVM, acupuncturist) is named and credentialed as formulator; her education, internship, and certifications are all disclosed. Where the disclosure falls short of a 10 is scope-of-involvement specificity: the brand describes the board as 'advisory' without explicitly disclosing per-product review responsibility, formulation veto power, or named ownership of specific SKUs. Buyers can verify WHO the experts are; they cannot fully verify WHAT each expert did on which product. Still, this is one of the stronger named-expert disclosures in the DTC pet supplement universe.Scope of involvement is described in general advisory terms without explicit per-product review attribution or formulation authorship beyond the founder.Dr. Amy Schnedeker, DVM, MS, DACVD - Board Certified Veterinary DermatologistNovember 14, 2026 testing review: four directly retrievable lot certificates cover Fish Oil, Multivitamin Soft Chews, Wellness Blend for Cats and Skin + Coat Goat Milk. The chew certificate is an actual Eurofins analytical report with microbiology and heavy-metal results. The other samples include contaminant, microbial and chemical-result tables, with some formulation quantities recorded under SOP QC. This is a strong public lot-linked program under tier 9; it is not merely a generic testing claim or an on-request-only service.Panel detail and attribution vary. The sampled chew report does not include ingredient-potency results; several other formula entries use SOP QC, and not every performing laboratory is named. Complete availability for every product and manufactured lot was not established.Check your product’s test results.November 14, 2026 manufacturing review: Fera identifies USA manufacturing, domestic and imported ingredients, and an FDA-registered GMP facility. NASC independently confirms that Fera passed a facility audit and earned QualitySeal permission. This verifies a named quality program with country-level manufacturing disclosure, matching tier 8.The reviewed current FAQ, independent NASC listing and sampled certificates do not name the manufacturing facility, city and state. NASC participation does not establish a lot-specific assay or clinical result.All our supplements are manufactured in the USABrand marketing stays inside supportable claim language. Product benefits are framed as 'supports,' 'helps,' 'eases occasional stiffness,' 'maintains healthy cartilage' — not disease-treatment or cure language. The home page hero does not assert 'clinically proven' or 'veterinarian-approved' claims; promotional copy emphasizes discounts and category positioning rather than clinical certainty. Where the brand uses 'clinically studied,' it points specifically to the named strain (DE-CA9) that does have a published trial — defensible. Fera does NOT publish disease-state claim language on the surveyed surface. The score holds below 9 because (a) the home page does not carry above-the-fold qualifying language ('not intended to diagnose...') visible to a casual buyer, (b) some product copy uses 'proprietary blend' marketing language even when the active panel is fully numerically disclosed, and (c) the brand's 'Vet Created' phrasing is broader than the actual scope of the Vet Advisory Board's per-product role.No above-the-fold safety qualifier. 'Vet Created' framing implies a tighter formulation tie than the advisory board's disclosed scope. 'Proprietary blend' marketing on dose-disclosed panels creates avoidable verbal friction.Helps Relieve Occasional Joint StiffnessEvidence pages are reachable within three clicks from the home page. Header navigation surfaces About and a quiz; the mega-menu and footer carry direct links to About Us, Vet Advisory Board, Sustainability (which hosts the COA lookup tool), FAQ, Ingredients, Store Locator, and Blog. The four pillars all have findable surfaces: science (Ingredients), evidence (PDP citations), experts (Vet Advisory Board), testing (Sustainability + COA Lookup). The accessibility ceiling is set by the absence of a single consolidated 'trust hub' — pillars are distributed across separate pages, so buyers must navigate to multiple destinations rather than landing in one evidence index. The home page above-the-fold also leads with promotional copy, not evidence framing.No single consolidated trust / evidence hub. Above-the-fold home page emphasizes promotions rather than evidence routing. Pillars are reachable but distributed.Utilize our COA search tool to check your product's test results.Testing/manufacturing updated November 14, 2026; other criteria May 23, 2026Sources: 14 sources reviewedIn-depth Fera Pets review →2FPFera PetsFera Pet OrganicsFera Pets presents above the DTC median on named-expert disclosure and operates a real lot-linked COA lookup. The brand publishes mechanism content with ingredient-level citatio...
3Rank78/100as of 2026-11-12Solid With Gaps3Rank
PetHonesty
Pet Honesty, LLC — per current company privacy policy
Dog and cat supplements78/100as of 2026-11-12Solid With GapsNumerical labels, named expert roles, public study accounts and an ORIVO oil-origin certificate; pooled components, formula matching, full study details and analytical testing scope remain limitations.
Public Evidence System Named ExpertsIngredient RationaleDisease-Claim-FreeNASC Audited Listing Clinical Evidence Published Made In USAWhat's in it
- Meaningful numerical labels across 15 sampled oral families
- Named experts with individual roles and public study accounts
- ORIVO species/origin certificate with oil batch identifiers
What's not in it
- Pooled components, obscured amounts and formula/version mismatches
- Study-summary access and uncertain current-formula matching
- Oil origin verification is not a full analytical COA for every product
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsFifteen oral families disclose meaningful nutrient or preparation quantities and serving bases across most sampled products.Pooled microbes and enzymes recur; dental and cat amounts can be grouped or obscured. Oil and joint gallery versions must not be silently treated as identical.The FAQ, Ingredients & Safety and product pages explain roles for many joint, calming, digestive and nutrient ingredients.Depth varies; some ingredients receive benefit summaries rather than complete selection, mechanism and dose rationale.Ingredient literature and dated in-home or owner-reported product studies are disclosed, including a 74-dog, six-week Melatonin Calming account.Full study methods, control results and analysis were not established in the reviewed routes; historical and current formulas cannot be assumed identical.Six profiles disclose credentials, biographies and individual roles; the actual Learn menu links the council page.Company-published roles do not independently establish present licensure, employment or involvement in every formula.ORIVO certificate 1742 identifies oil species, Alaskan origin and verified batch identifiers; ORIVO names its laboratory role.The program verifies species/origin, not full contaminant, microbial or potency results across the oral line. No all-product COA claim is made.The FAQ names quality systems and NASC lists audited supplements; product labels give manufacturing-country information.Country claims vary: sampled Squeezables say Made in Thailand despite the blanket USA FAQ. No named-factory or formula-to-facility map is established.Directions, cautions, veterinary guidance and dated or owner-reported study qualifications are publicly available.Broad science and results wording, dental study claims and inconsistent web panels need scope; these are disclosure findings, not allegations of unsafe products or dishonest intent.Product panels, the linked expert council, ingredient information, references and a public ORIVO batch route can be inspected.Full product-study reports and complete analytical testing results are not established through the declared routes; the sparse research landing is only one surface.Evidence and editorial review November 12, 2026Sources: 56 criterion/article sources + 2 identity sources; 15 oral product familiesIn-depth PetHonesty review →3
PetHonestyPet Honesty, LLC — per current company privacy policyNumerical labels, named expert roles, public study accounts and an ORIVO oil-origin certificate; pooled components, formula matching, full study details and analytical testing s...
4Rank77.5/100as of 2026-06-13Disclosure Gaps4Rank
YuMOVE
Lintbells Ltd
United Kingdom77.5/100as of 2026-06-13Disclosure GapsYuMOVE publishes joint-formula study summaries and ingredient papers, a named current veterinary team, and NASC programme disclosure. The current US navigation links experts and veterinary resources; public lot results remain unresolved.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWhat's in it
- Current primary navigation links named veterinary advisers and technical-team biographies with credentials and role descriptions.
- Public veterinary resources separate the RVC joint-formula study summary from ingredient papers and link the manufacturer detailer.
- The manufacturer detailer and independent NASC sources document a quality programme including random third-party product testing; USA manufacture is stated.
What's not in it
- The reviewed materials do not name the testing laboratory or provide public lot-linked YuMOVE test results.
- The RVC trial is publicly presented as a data-on-file summary, with finished-formula identity and catalog coverage to be checked for the exact product.
- Manufacturing disclosure is country-level; the reviewed sources do not name an actual facility, city and state.
Why this score— —Why this scoreWhat's missingBrand's own wordsC4 8→10, C5 4→6, C6 7→8 and C8 6→8; total 68.5→77.5. Four other numerical criteria retain original dates; this is not a new full assessment.Sources: 19 dated source records; individual evidence dates retainedFull per-criterion evidence: public dataset ↗In-depth YuMOVE review →4
YuMOVELintbells LtdYuMOVE publishes joint-formula study summaries and ingredient papers, a named current veterinary team, and NASC programme disclosure. The current US navigation links experts and...
5Rank77/100as of 2026-11-12Solid With Gaps5Rank
PetLab Co
PetLabCo. — subsidiary of PetLab Group Ltd, per current Terms
Dog and cat supplements77/100as of 2026-11-12Solid With GapsQuantitative labels, detailed expert roles, a published probiotic-recipe study and specific testing commitments; recurring blends, formula matching, dental-report access and lot-level documents remain limitations.
Public Evidence System Named ExpertsIngredient RationaleDisease-Claim-FreeNASC Audited Listing Published Trial: Tested Recipe Made In USAWhat's in it
- Quantitative product panels with defined serving bases
- Named expert profiles with described roles
- Published probiotic-recipe study and specific testing commitments
What's not in it
- Recurring pooled blends and formula/version boundaries
- Current-versus-studied recipe identity and full dental-report access
- No named product-quality laboratory or public lot-report route established in reviewed sources
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsTwenty oral product pages provide numerical panels and serving bases; related variants are grouped into 18 families.Meaningful microbial totals and some other ingredients remain pooled. Joint versions, cell counts, compound masses and serving formats must be distinguished.Ingredient-role explanations span digestive, joint, dental, skin and newer products.Some actives use benefit summaries rather than complete selection, mechanism and dose rationales. Biological roles do not prove each finished formula’s effects.Zilinger et al. published a company-funded probiotic-recipe trial (DOI 10.3390/pets3010001); dental pages describe study durations and endpoints.The studied and current probiotic recipes differ in disclosed carrier/ingredient wording; equivalence is unestablished. Full dental reports were not established in reviewed routes.Seven primary-navigation expert profiles disclose credentials, biographies and roles in formulation, dental work, clinical coordination and cat products.Company-published roles do not independently establish present licensure or every-formula involvement; prospective 2024 longevity-trial wording is not current-status proof.About describes batch contaminant testing and independent third-party purity, potency and label checks; NASC lists audited supplement participation.No named product-quality laboratory, public lot lookup or bottle-specific results were established. Clinical biological-sample labs are not automatically product-quality labs.Product pages disclose US manufacture with domestic/global ingredients; About describes NASC/FDA/cGMP-guideline facilities.Country-level and program disclosures do not identify each factory by name, city and state or establish a formula-to-facility map.Support wording, directions and cautions are generally qualified; the dental guide preserves brushing and professional care.The ProBright PDP’s toothbrushing wording needs that context. DF-14’s “Promotes Longevity” has no matched lifespan trial in reviewed sources; broad assurances and 29/31-day wording also need qualification.Primary navigation exposes About, Experts and Ingredients; readable product panels and detailed profiles are public.The probiotic paper requires external citation follow-up; reviewed dental routes provide summaries rather than full reports. No consolidated public lot-document route was established.Evidence and editorial review November 12, 2026Sources: 36 criterion/article sources + 2 identity sources; 20 oral product pages, 18 related familiesIn-depth PetLab Co review →5
PetLab CoPetLabCo. — subsidiary of PetLab Group Ltd, per current TermsQuantitative labels, detailed expert roles, a published probiotic-recipe study and specific testing commitments; recurring blends, formula matching, dental-report access and lot...
6Rank77.0/100as of 2026-11-14Solid With Gaps6Rank
VetriScience Laboratories
FoodScience, LLC
Dog and cat supplements77.0/100as of 2026-11-14Solid With GapsReadable serving-based panels in the declared 12-product sample, current research summaries and named development roles. Some blends remain grouped; full-report access and public lot-report access are limited. This 77.0/100 editorial assessment measures disclosure, not clinical efficacy.
Public Evidence System Named ExpertsIngredient RationaleDisease-Claim-FreeNASC Member Clinical Evidence Published Made In USAWhat's in it
- Current sampled product panels disclose serving-based quantities in readable HTML.
- The science hub and accessible 2024 Reference Guide provide study details with product/design limits.
- Pedro Machado and Elizabeth DeLomba have named roles, credentials and development context in primary navigation.
- Brand and parent quality programs describe testing and manufacturing; NASC confirms program identity.
What's not in it
- Calming biopeptides, dental probiotics and Healthy Gut & Digestion capsule ingredients retain grouped amounts; the sample is not a catalogue census.
- Most research summaries lack matched full-report links; ingredient, disease-model, cell and human studies do not validate every finished formula.
- No named analytical laboratory, public current lot report or buyer lot lookup was located in the declared source set. This does not establish absence of internal testing.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsTwelve current product pages disclose defined servings and individual active/nutrient amounts in HTML across dog/cat and several formats. This corrects the image-only premise.Calming biopeptides, dental probiotics and Acetylator remain grouped. Dental and Acetylator omit probiotic CFU. The sample is not a catalogue census or potency test.The primary-navigation ingredient hub and sampled product/science pages explain roles across categories, including cartilage structure, bacterial binding, prebiotics and HMB/protein metabolism. Primary papers provide citable contexts for some mechanisms.Many entries remain short benefit lines or broad assertions. There is no complete, cited selection-and-dose rationale for every meaningful active.Five current product-research summaries give study designs/endpoints. The readable official 2024 guide names investigators or study organizations and supplies detail. The current hub explicitly distinguishes select complete-formula studies from ingredient research.Documents are distributed. The current hub does not link matched full reports for most summaries. HMB ingredient research and the finished-formula owner project have different designs. These summaries are not uniformly full journal papers.The primary-navigation expert page names Pedro Machado, DVM/MSc/PhD, as FoodScience VP of R&D leading VetriScience formulation strategy, evidence planning and development. Dr Elizabeth DeLomba, DVM/MBA, has a named consultant role, educational biography and product-development contributions since 2017.These are public role and credential disclosures, not independent licensure checks, authorship of every formula, or expert review of our article.Brand quality/FAQ pages describe third-party ingredient purity/consistency testing, label-claim checks and NASC random testing. NASC independently lists FoodScience including VetriScience as audited for supplements. The parent describes raw-material identity, purity, strength/composition and label checks.No named analytical lab, public current lot report or buyer lookup was located in this declared source set. NASC is a program body, not a named testing laboratory. Program descriptions do not prove results for every lot.The brand describes Vermont manufacture, SQF/cGMP and global ingredient qualification. The parent describes FDA-registered Vermont facilities and Williston/Colchester history. NASC corroborates program identity.Exact current SKU-to-plant assignment and certificate scope/dates were not verified. A business address or corporate history is not a factory map. FDA registration is not product approval.The brand distinguishes ingredient and select formula research and gives cautions/consultation guidance. Multiple clinical headlines nevertheless need scope: the HMB owner project does not measure objective muscle strength; Amilextin's summary is stronger than its reported within-group statistics; dental calculus is described as a trend.This criterion evaluates confidence against disclosed evidence. It is not a finding that products are ineffective or the company dishonest. No litigation allegations or penalty for lacking a trial on every formula.Primary navigation directly offers Our Quality, Backed by Science, VetriExperts and Ingredients. Current product panels and warnings are readable HTML without an account or support request.Evidence is distributed across top-level routes; older guides and primary papers require further discovery. A single consolidated trust landing page or public lot lookup was not demonstrated.Evidence and editorial review November 14, 2026Sources: 27 public source records; 12 current product panels; not a catalogue censusIn-depth VetriScience Laboratories review →6
VetriScience LaboratoriesFoodScience, LLCReadable serving-based panels in the declared 12-product sample, current research summaries and named development roles. Some blends remain grouped; full-report access and publi...
7Rank75.5/100as of 2026-07-03Solid With Gaps7Rank
AnimalBiome
Animal Microbiome Analytics, Inc. dba AnimalBiome
Oakland, CA75.5/100as of 2026-07-03Solid With GapsAnimalBiome publishes peer-reviewed FMT capsule research, named scientific experts and donor-screening detail. Study design, disease-specific findings, grouped mushroom amounts and the dates of manufacturing/COA checks remain important limits.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Published FMT Capsule Trial Named Mfg FacilityWhat's in it
- Named scientific and veterinary leaders, including four named PhDs, are publicly visible on the team page under primary navigation.
- Gut Restore donor and batch screening names two independent third-party labs (IDEXX Reference Laboratories and Antech Diagnostics) with specific pathogen panels.
- Peer-reviewed capsule studies in cats and dogs and a small controlled trial are publicly readable; the Research Studies page links the observational capsule papers.
What's not in it
- The July 3, 2026 source review did not locate public lot-linked COA or manufacturing-facility/certification disclosures; these criteria are carried forward with that date.
- Observational findings and a small disease-specific controlled trial do not establish broad efficacy. The controlled relapse comparisons were nonsignificant; the 2019 pilot write-up remains separate sponsored trade content.
- Conventional dose/potency metrics are not disclosed for the flagship Gut Restore capsule, and a secondary product (Skin Rescue) groups eight mushroom species into one blend total without species-level amounts.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsDisclosure varies across the declared three-family sample. The prior numerical tier is retained. On the flagship Gut Restore, AnimalBiome discloses the active source material, inactive ingredients, Small/Medium/Large capsule-size variants, and weight-based use directions, but the Active Ingredients panel names only the source material (screened fecal matter) with no CFU, strain/species composition, or batch-specific microbial-abundance figure -- a structural gap inherent to an FMT/donor-material product rather than a proprietary-blend concealment. Verification pulled two additional product pages to test the modal line: S. boulardii + FOS discloses full per-active quantities ('Saccharomyces boulardii CNCM I-3799, 6.6 Billion CFU' and 'GOFOS(TM), 225 mg' per scoop) with Inactive Ingredients stated as 'None' and no blend. Skin Rescue discloses most actives by per-weight-tier mg amount but groups eight mushroom species into a single 'Organic Mushroom Blend' mg total without species-level breakout, which is a genuine grouped/proprietary-style disclosure gap on a secondary product. That mix -- one fully quantitative product, one mostly quantitative product with one grouped blend, and a flagship with no quantitative active panel at all -- matches tier anchor 7 ('Disclosure is strong on the flagship but inconsistent across the broader line -- multiple products use proprietary blends or grouped amounts') more closely than anchor 8, because the flagship itself carries the largest disclosure gap rather than being the strongest-disclosed SKU.The flagship's active identity and use directions are public, but microbe counts, community composition, and lot-specific potency-style metrics are not disclosed in a standard panel; a secondary product (Skin Rescue) also groups eight mushroom species into one blend total without species-level amounts; other actives are separately quantified.Extensively-screened canine fecal material sourced from healthy donors who are fed a balanced diet.AnimalBiome publishes a clear scientific rationale for microbiome testing and FMT-style supplementation, and verification confirmed this extends past the flagship. The science page explains sequencing, healthy reference sets, missing beneficial bacteria, harmful bacteria, and restoration logic mapped to product categories. The Gut Restore PDP and donor-screening page connect the formulation to screened donor material and delayed-release capsules. Verification pulled two secondary products to test consistency: the S. boulardii + FOS page carries dedicated 'About Saccharomyces boulardii' and 'About Fructooligosaccharides (FOS)' sections that explain mechanism specifically -- e.g., that S. boulardii is a yeast (not bacteria) that survives stomach acid and produces short-chain fatty acids that support the gut barrier, and that FOS is a prebiotic fiber that feeds beneficial microbes -- which is genuine ingredient-level mechanism content, not just benefit language. Skin Rescue's rationale is thinner by comparison (a 'gut-skin axis' and 'postbiotic' framing with per-ingredient callouts, e.g. quercetin as 'nature's benadryl') but still connects ingredients to a stated mechanism rather than benefit assertions alone. This pattern -- flagship and most secondary products carrying real rationale, with only one secondary product's mechanism explanation being noticeably thinner -- matches tier anchor 9 ('rationale is published for the flagship and most secondary products, with only minor meThe microbiome mechanism is well explained on the flagship and on S. boulardii + FOS, but Skin Rescue's ingredient-level rationale is comparatively thinner, and several 'studies have shown' mechanism claims on secondary products are not linked to a specific citation on-page.We are a company founded and led by scientists, taking an innovative and scientific approach to everything we do.The declared three-family sample is Gut Restore, S. boulardii + FOS and Skin Rescue. Gut Restore has peer-reviewed capsule studies in 46 cats (2023) and 54 dogs (2024), linked through Research Studies. A separate 2024 randomized, blinded, placebo-controlled study used AnimalBiome-supplied finished FMT capsules in 14 dogs with tylosin-responsive enteropathy. The S. boulardii page links real journal research. Thus two of three sampled families cite real studies, meeting tier 8; this is not a claim about the entire catalogue.The cat and dog cohorts are observational. The controlled trial used single-donor capsules for four weeks, with four weeks of follow-up; relapse comparisons were not statistically significant (p=.433 during treatment, p=.56 afterward). Company involvement is disclosed. These findings do not establish broad retail-product efficacy. Skin Rescue retains unlinked clinical-style claims; the separate 2019 sponsored pilot write-up is not a peer-reviewed paper.AnimalBiome publicly names scientific and veterinary leaders, including a PhD co-founder/chief science officer and a DVM/MSc/PhD VP of Microbial Discovery. Verification confirmed the Meet the Team page is reachable through the primary navigation (nested under the 'About Us' menu, not footer-only or search-only) and, on refutation-probing that same already-cited page, found two additional named PhDs beyond the two originally logged: Connie Rojas, PhD (Director of Field Trials and Senior Scientist) and Katie Dahlhausen, PhD (Product Manager II, Supplements) -- the latter role title explicitly ties a named PhD to the Supplements line. The Our Company page independently corroborates Holly Ganz's Founder/Chief Science Officer role. That combination -- at least one named expert (in fact several) fully surfaced with credentials and role, secondary expert involvement documented across additional named PhDs, reachable via primary navigation -- matches tier anchor 9 rather than anchor 8, which is reserved for names reachable only via deep navigation or with partial credentials. It falls short of anchor 10 because no biographical context or explicit scope-of-involvement narrative is given for any named person -- titles are stated but not what each person actually does day-to-day, and no page states which named person reviewed or signed off on a specific formula.Named credentials and titles are visible for multiple scientists, but no page states biographical context or which named person reviewed or signed off on a specific formula.Niokhor Dione, DVM, MSc, PhDJuly 3, 2026 assessment (numerically carried forward): AnimalBiome discloses a substantive screening program for Gut Restore donor material. Verification read the donor-screening page in full and found it names two independent third-party laboratories, not one -- IDEXX Reference Laboratories and Antech Diagnostics -- and states the pathogen/parasite PCR panel covers 'routine donor and batch screening,' listing specific named organisms (e.g. Salmonella spp., Giardia spp., canine parvovirus 2, Toxoplasma gondii) rather than generic 'we test for pathogens' language. This is unusually specific for a microbiome supplement. Verification also actively searched for a COA or lab-report page: the full sitemap (159 /pages/ URLs) was enumerated and no COA, lab-results, certificate-of-analysis, or batch-report page was found, and none of the 12 pages fetched during this review contain COA text. That absence held up under refutation attempts. Because lot-level COA access here is not 'partial or available on request' (tier anchor 8) but is not present in any form, and the disclosed testing -- while lab-named and detailed -- is not connected to a buyer-visible specific lot or finished-capsule potency figure, this stays at tier anchor 7 ('Testing is referenced publicly, but COA access is limited, generic, or not connected to specific lots') rather than moving up to anchor 8.In the July 3, 2026 source set: Donor and batch screening is detailed and names two labs (IDEXX, Antech), but no public lot-linked COA, finished-capsule potency report, or on-request COA statement was found anywhere on the site after a full sitemap search.Donor stool samples are submitted for parasites and pathogen screening to the IDEXX Reference LaboratoriesJuly 3, 2026 assessment (numerically carried forward): AnimalBiome discloses quality-control intent and substantial donor-material sourcing logic, but not a facility-level manufacturing system. The science page states quality and safety are central and references third-party testing and 'gold standard' quality-control processes, but that sentence names no facility, certification body, or lab. The donor-screening page gives strong, verified input-control detail (two named labs, specific pathogen panels). Verification actively searched for manufacturing/facility disclosure across all 12 archived sources plus the full 159-URL /pages/ sitemap and the Our Company (about/mission) page: no cGMP, HACCP, FDA-registration, NASC membership, SQF, or ISO certification term appears anywhere, and no facility name, city, or state for capsule production is disclosed (the only address found is the Oakland, CA corporate/HQ address on the patents and contact pages, not a stated manufacturing site). This mixed picture -- real, specific, verifiable sourcing/screening detail for donor input material, but zero verifiable disclosure for the actual manufacturing/production step -- keeps this at the middle tier rather than the more generic anchor 4 (which requires no sourcing detail at all, not met here) or a higher anchor (which requires named facility or certification, not found after an exhaustive search).In the July 3, 2026 source set: The public pages do not name a manufacturing facility, disclose cGMP/HACCP/FDA-registration/NASC/SQF/ISO status, or state batch-release rules for finished capsules, despite a full-site search including the sitemap and about-us page.We conduct third party testing on our supplements and follow the gold standard of quality control processes.Peer-reviewed capsule research and a controlled trial must be credited alongside modality-level citations. The current Skin Rescue page still uses clinical-style assurances and outcome percentages without a linked study for those claims. The broader root-cause headline remains more confident than the disease-specific, observational and nonsignificant controlled findings establish. The numerical tier remains 7.Readable research does not substantiate every broad benefit claim. The controlled trial did not show a statistically significant relapse advantage; the reviewed Skin Rescue claim remains insufficiently linked to a study.Resolve the root cause of diarrhea, soft stools, and itchy skinThe current primary-navigation Research Studies page links the 46-cat and 54-dog capsule papers directly. Research is therefore not confined to the older off-navigation pilot page. The original July 3 review also identified science, testing and named-expert navigation; manufacturing-access findings retain that earlier source date. The accessibility score remains 8.Evidence remains distributed. The July 3 source review did not locate manufacturing disclosure; that finding was not renewed as a current whole-site search.Microbiome ScienceResearch updated November 14, 2026; other criteria July 3, 2026Sources: 12 sources dated July 3 plus 6 current research/product source recordsIn-depth AnimalBiome review →7
AnimalBiomeAnimal Microbiome Analytics, Inc. dba AnimalBiomeAnimalBiome publishes peer-reviewed FMT capsule research, named scientific experts and donor-screening detail. Study design, disease-specific findings, grouped mushroom amounts ...
8Rank75/100as of 2026-11-11Solid With Gaps8Rank
Vetoquinol USA
Vetoquinol USA, Inc.
Fort Worth, TX, United States75/100as of 2026-11-11Solid With GapsThe manufacturer shop supplies omega quantities and Zylkene panels missed by the earlier review. Named veterinary contributors, study references and group manufacturing disclosures are public, with product and date limits.
Public Evidence System Named ExpertsIngredient RationaleDisease-Claim-FreeNASC Program Clinical Evidence Published Disclosed Production SitesWhat's in it
- EPA and DHA quantities for the liquid pump
- Named veterinary technical and education roles
- Public group manufacturing and quality-system disclosures
What's not in it
- A current Zylkene Plus campaign label has inconsistent serving information
- Studies concern different ingredients and formulas
- Group quality disclosures do not identify the lab report for an individual US supplement lot
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsThe liquid pump lists1,000 mg fish oil, at least180 mg EPA and120 mg DHA per1 mL, plus vitamin quantities. Classic Zylkene lists75/225/450 mg hydrolyzed bovine milk protein providing alpha-casozepine, and Flexadin lists its UC-II and undenatured-collagen amounts.The hydrolyzed-protein quantity is not isolated alpha-casozepine mass. The directly retrieved current Zylkene Plus450 shop panel states a0.250 g capsule containing450 mg milk hydrolysate and omits the fish-hydrolysate amount despite describing it as an ingredient. This secondary-product inconsistency prevents near-complete disclosure credit.The product family pages explain UC-II collagen, fish-oil omega roles and the milk-derived calming ingredient, but the explanations are dispersed and some are mainly benefit statements.Meaningful ingredient logic is public, but the reviewed pages do not explain the biology of every meaningful active consistently. This retains tier6 on a fresh review, rather than treating the original score as verified.Flexadin cites D'Altilio2007. The Zylkene campaign supplies Beata2007 and Porcheron2023 references, rather than having no research.The UC-II trial is ingredient-specific; Porcheron concerns the combination with white-fish hydrolysate and cannot be transferred automatically to classic Zylkene. Some corporate clinical claims lack a direct matching citation. This fits uneven citation/ingredient borrowing, not an absence of trials.A July2026 article identifies Acacia Roman,DVM,Technical Services Veterinarian. The April2025 VeRBS announcement names credentialed educators including Duncan Lascelles and Marie Bartling and states their rehabilitation-education scope.Technical service and education are actual disclosed roles; no claim is made that these people formulated every supplement. Full primary-navigation biographical coverage needed for 10 was not established.The 2025 group report describes raw-material and finished-product control/release and environmental compliance; the US NASC page describes auditing and adverse-event systems. This is meaningful quality/testing information, not generic marketing alone.The group-level report does not connect each sampled US supplement to a named analytical laboratory, tested panel or buyer-visible lot result. An equine-only named-lab program found separately is not transferred to this sample.The 2025 report identifies production sites including Lure/Magny-Vernois and Tarare and describes site-dependent quality systems. The US site separately identifies NASC auditing and cGMP requirements.The report expressly distinguishes nonmedicinal Tarare from GMP plants. It does not establish that every supplement has every group certification, nor does it map each sampled SKU to its factory. Facility and system disclosure is strong but incomplete at that resolution.Joint and calming marketing includes clinical-style language while cited research varies by ingredient/formula. Zylkene Plus provides a published real-world-evidence citation but bases its proven-palatability claim on data on file, which buyers cannot inspect from the page.This scores uneven public qualification, not whether the products work. The liquid's actual EPA/DHA panel is recognized rather than incorrectly called absent.Corporate navigation exposes product and NASC pages, and links the group site; label detail is public on the manufacturer shop. Expert news and the annual report require deeper navigation across these official properties.One or two evidence pillars are dispersed/deeper rather than in a single three-click trust hub. The indexed campaign has a failed direct fetch, recorded as an access limitation rather than proof that the cited study does not exist.Evidence reviewed Nov 11, 2026Sources: 13 source records; representative product sampleIn-depth Vetoquinol USA review →8
Vetoquinol USAVetoquinol USA, Inc.The manufacturer shop supplies omega quantities and Zylkene panels missed by the earlier review. Named veterinary contributors, study references and group manufacturing disclosu...- 9RankNP
Native Pet
Native Pet
St. Louis, Missouri75/100as of 2026-11-11Solid With GapsQuantitative sample labels and a named nutritionist; pooled probiotics, scattered research and product-specific certification retain important limits.
Public Evidence System Named ExpertsIngredient RationaleDisease-Claim-FreeNASC Audited Listing Clinical Evidence Published Made In USAWhat's in it
- Quantitative facts panels across all four sampled dog formulas
- Dr. Dan Su is named with credentials and formulation role
- Ingredient explanations, linked research and an independently documented NASC quality signal
What's not in it
- Senior Daily and Skin + Coat pool probiotic quantities
- The available Clean Label Project certificate lists only The Daily and does not establish current annual renewal
- No lot-linked analytical-report route or matching finished-formula study located in the reviewed sources
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsFour visually checked dog-formula panels quantify stated active lines. The Daily divides 2 billion CFU into 1 billion per named organism.Senior Daily and Skin + Coat retain pooled secondary probiotics. This near-complete finding covers the four-formula sample, not every SKU or cat product.Sampled pages explain ingredient roles; the glucosamine article adds biological discussion and research links.Some actives receive benefit descriptions rather than mechanisms; not every selected amount is explained. This is rationale disclosure, not confirmed finished-formula benefit.Educational content links identifiable research, including a real 2007 canine osteoarthritis review. The Daily labels its customer findings a survey.Research is scattered rather than consistently mapped to current formulas and doses. No matching finished-formula trial was located in the declared sources.Home/product pages name Dan Su, MS, DVM, DACVIM (Nutrition), with a formulation role; the 2026 company announcement calls him in-house formulator.A complete primary-navigation biography was not established. Credentials are manufacturer-disclosed, not independently checked against a board registry here.The Daily states supplements are tested/audited. A separate Clean Label Project certificate identifies The Daily, its UPC and issuer Ellipse Analytics.The certificate is product-specific, requires annual renewal not verified here, and is not a lot report. Neither the program nor issuer is assumed to be the assay lab.The wholesale page states USA manufacture; NASC’s directory independently lists Native Pet as audited for supplements.No named factory/city/state or SKU mapping was established. The certificate’s St. Louis address is not treated as a factory; NASC is not clinical approval.Ingredient support wording and expressly identified customer-survey results provide some qualification.Other broad efficacy/competitor claims and an unsourced 80% manufacturing statistic lack matched support. This does not prove the statistic false or products ineffective.Public product pages show labels, roles and ingredients; the blog is in main navigation. Wholesale and certificate sources add deeper evidence.Testing/manufacturing remain distributed, without a consolidated trust hub. Image labels and transport errors are not treated as evidence absence.Evidence reviewed Nov 11, 2026Sources: 17 source records; declared sampleIn-depth Native Pet review →9NPNative PetNative PetQuantitative sample labels and a named nutritionist; pooled probiotics, scattered research and product-specific certification retain important limits.
10Rank75/100as of 2026-11-14Solid With Gaps10Rank
Purina Pro Plan Veterinary Supplements
Nestlé Purina PetCare Company
St. Louis, MO75/100as of 2026-11-14Solid With GapsPurina publishes quantified labels, named researchers and strain-specific references through Purina Institute. Study coverage and exact-formula matching vary, and corporate quality statements do not supply a public report for the buyer's lot.
Public Evidence System Named ExpertsIngredient RationaleDisease-Claim-FreeNASC Member Clinical Evidence Published Made In USAWhat's in it
- Quantified probiotic and soft-chew labels
- Named scientific contributors with stated roles
- Public probiotic research references and biological explanations
What's not in it
- Grouped EPA/DHA and unquantified individual Hydra Care osmolytes
- Uneven research matching across the sampled product families
- No lot-linked analytical-report route located in the identified sources
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsThe sampled powders disclose SF68 or BL999 CFU; FortiFlora PRO discloses 1.0 g psyllium per 2 g sachet. Joint/Skin Care list active amounts and Multi Care lists inulin, vitamin E and B. coagulans. Most sampled products therefore have meaningful per-active quantities.Joint and Skin Care combine EPA+DHA, while Hydra Care's guaranteed analysis does not quantify each osmolyte. The sample does not support an every-product score of 10.The Institute explains probiotic competitive exclusion, fermentation products and the gut-brain axis, with references. Product pages explain ingredient roles for joint, skin and hydration functions.Some secondary actives are described principally by benefits; the public record is not an active-by-active mechanistic rationale for the entire line.The Institute gives identifiable SF68 papers and BL999 research references. It explicitly says probiotic effects depend on strain and dose. The references include full papers, symposium proceedings and a conference abstract.Citation coverage is uneven across the seven product families. A strain study is not automatically a study of every current finished formula; the reviewed Joint/Skin product pages do not consistently connect each clinical-style statement to a matching study.Ragen T. S. McGowan is identified with a PhD, a Purina research/product-development role and a biography in the 2025 Global Summit material; she presents BL999 work. Michael Lappin is identified as an SF68 researcher on the Institute page.This establishes named scientific involvement, not authorship of every supplement. The summit biography is deeper than a unified brand expert hub, so the primary-navigation/full-biography requirements for 10 are not all met.NASC lists Nestlé Purina PetCare as audited for supplements; its programme requires random independent-lab product testing. Corporate check counts are not supplement/lot counts.Programme records do not name the lab or provide brand-specific results, full panels or individual product/lot coverage.Sampled pages state US production, and Skin Care identifies the NASC quality-system signal. Our Difference describes owned US facilities.The reviewed supplement pages do not map each SKU to a named manufacturing facility or disclose a certificate for every product. The NASC observation is scoped to the pages displaying it, not silently transferred to the whole catalogue.Many pages use support-oriented language and the Institute explains strain/dose limits, while the commercial supplement pages also use clinical-style efficacy language without consistently supplying a directly matching citation on that page.This is a judgment about claim-to-public-evidence presentation, not a finding that the efficacy claims are false.Product and Our Difference navigation is public; Institute science pages have primary-navigation research links. Finding the named-researcher biography and connecting the shopping site to the separate Institute evidence still required targeted searching in this audit.Multiple official domains are not themselves an adverse fact. No claim is made that all evidence is missing or account-gated, and failed automated access is not the basis for this tier.Evidence reviewed Nov 11, 2026Sources: 11 source records; representative product sampleIn-depth Purina Pro Plan Veterinary Supplements review →10
Purina Pro Plan Veterinary SupplementsNestlé Purina PetCare CompanyPurina publishes quantified labels, named researchers and strain-specific references through Purina Institute. Study coverage and exact-formula matching vary, and corporate qual...
11Rank74.5/100as of 2026-11-11Solid With Gaps11Rank
Nutramax Laboratories
Nutramax Laboratories Veterinary Sciences, Inc.
Lancaster, South Carolina74.5/100as of 2026-11-11Solid With GapsNutramax scores 74.5/100 under the existing public-disclosure rubric. The reviewed core product families publish substantial label and manufacturing information, named veterinary leadership and specific testing processes. Public research exists; citation placement and batch-result access remain less complete.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWhat's in it
- Named active panels across the sampled core families, with grouped amounts identified rather than overlooked.
- Owned Lancaster manufacturing, specific internal quality steps and a dated independent UL GMP audit disclosure.
- Named veterinary executive leadership and public research sources receive credit under their actual disclosed scope.
What's not in it
- Representative sample of five established product families, with Senior checked for variation; not every current or historical SKU.
- No current UL certificate or exact finished-product batch analytical results independently verified.
- Public citation navigation is uneven; not all research is unavailable and not every product claim was clinically validated.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsThe sampled Cosequin MSM tablet, Dasuquin MSM soft chews, Denamarin chewable tablet and Welactin Advanced 3TA liquid publish named active amounts and serving directions. Proviable-DC identifies seven strains but guarantees their combined CFU count. Dasuquin Senior provides individual core amounts and a separately named three-ingredient blend total.This is a five-family representative sample with Senior as a variation check, not a census of every Nutramax SKU. ASU values are standardized powder amounts; EPA+DHA totals are not separate EPA/DHA amounts.Denamarin explains SAMe, glutathione and silybin with references; Dasuquin explains cartilage roles and its ingredient combination; Proviable explains the different roles of probiotics and prebiotics. Explanations on the sampled Cosequin and Welactin pages are shorter and predominantly benefit-oriented.The score describes the consistency of public explanations, not whether the ingredients work or every mechanism is clinically established at the supplied dose.Denamarin publishes author/journal references linked to public records. The reviewed Proviable and Dasuquin product pages use research language without consistently placing full study identification next to the claim. Public journal papers on Proviable-DC and Dasuquin with MSM are accessible outside the professional portal.Those papers do not establish every claim, all six advertised Proviable studies, all current formulas or Dasuquin Senior outcomes. External discoverability corrects the old all-evidence-gated implication; it does not automatically turn every product page into a well-cited page.Public Nutramax news materials name Todd Henderson, DVM, as President and CEO. The quality-audit announcement also names Godwin Omorogieva as Vice President of Quality. These identify people and their disclosed company roles, although they are found in media material rather than a consolidated expert page.Executive leadership is the role verified for Henderson; it is not proof he formulated or reviewed each product. Omorogieva is named with a role, but no professional credential is inferred.The public quality process distinguishes raw-material analytical chemistry and microbiology, internal raw-material COAs, in-process checks, finished-product testing in Nutramax chemistry/microbiology laboratories and stability testing. These are specific testing disclosures.The reviewed quality, product and media sources do not provide a purchaser-facing finished-product lot-to-COA lookup or an enumerated contaminant panel with batch results. This finite finding does not establish that testing or COAs do not exist. A facility auditor is not treated as the product-testing laboratory.Nutramax identifies owned manufacturing in Lancaster, South Carolina; product contact information supplies the Quality Drive address. Its primary-navigation quality page explains supplier approval, incoming-material checks, cGMP/SOPs and production controls. The May 26, 2022 announcement identifies a UL-administered independent GMP conformance assessment.The reviewed public sources do not supply current audit scope or renewal details, or complete ingredient-origin traceability. The 2022 announcement is historical disclosure; this does not establish that current certification or sourcing records are absent.The sampled product pages primarily use support language and attach survey attribution to veterinarian-recommendation statements. Some research/combination wording is more categorical than the study identification supplied beside it, particularly on Dasuquin and Proviable.This is a sampled disclosure assessment. Survey raw data, every historical advertisement and the clinical substantiation for every support claim were not audited. A study-access gap is not a finding that the advertised benefit is false.Quality and manufacturing explanations are linked from corporate navigation. Product facts and some references are public across the product domains. Named leadership appears in media material, and additional research is accessible through public journals.Finding the whole record requires moving between product domains, media pages and journal sources; it is not all assembled in a single buyer evidence hub. Professional access is not the only route to all studies.Reviewed November 11, 2026Sources: Dated primary sources; criterion mappings in the datasetIn-depth Nutramax Laboratories review →11
Nutramax LaboratoriesNutramax Laboratories Veterinary Sciences, Inc.Nutramax scores 74.5/100 under the existing public-disclosure rubric. The reviewed core product families publish substantial label and manufacturing information, named veterinar...
12Rank74.5/100as of 2026-11-13Solid With Gaps12Rank
Four Leaf Rover
Legal manufacturer not established in this scoped review
Pet supplements74.5/100as of 2026-11-13Solid With Gaps74.5/100 following a finite November 13, 2026 reassessment. Current official galleries disclose numerical labels, Dr Patricia Jordan DVM is named as a formulator, and NASC confirms audited seal eligibility. Remaining gaps concern grouped ingredients, citation context and access to product-specific testing reports.
Public Evidence System Named DVM FormulatorIngredient RationaleDisease-Claim-FreeNASC Audited Listing Clinical Evidence Published Made In USAWhat's in it
- Numerical panels were inspected for all 22 standalone oral formulas or foods in the declared sample; the additional offer is a three-product bundle.
- Our Story and gallery artwork identify Dr Patricia Jordan DVM’s formulation role.
- The homepage describes an own GMP-compliant Texas plant and testing results on request; NASC independently confirms audited Quality Seal eligibility.
What's not in it
- Six of 17 supplement-style panels retain meaningful grouped ingredient or probiotic declarations; food-analysis panels use a different format.
- Research identifiers are real but incomplete, and Safe-Sea’s broad comparison needs preparation/species/endpoint context.
- No public lot-report lookup or named performing laboratory was established in the reviewed source set.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsAll 22 standalone items reviewed have numerical Product Facts or food-analysis panels; 17 supplement-style panels include 11 with individual entries and six with meaningful grouping.Grouped herbs, enzyme ingredients and probiotic counts limit individual dose disclosure. Food nutrition panels are evaluated as such, not treated as missing supplement labels.Current pages explain ingredient roles across probiotic, prebiotic, enzyme, fatty-acid, mushroom and botanical products.Depth varies, and several benefit or mechanism assertions are not tied to a mapped study. Rationale disclosure is not a validation of every mechanism.Safe-Sea names a 1997 journal paper; Oral Probiotics expressly attributes research to OraCMU and AstaReal ingredients.Citation work is sparse and requires buyer interpretation. Safe-Sea’s broad comparison does not identify the primary study’s rat-model/Lyprinol context; missing formula trials alone is not an adverse finding.Our Story credits Dr Patricia Jordan with formulating most products. Gallery artwork visibly identifies her DVM qualification and formulation role.A consolidated biography and complete per-product involvement account were not established. This credits public attribution, not independent current licensure or employment verification.The homepage offers third-party test results on request. Product pages describe purity/contaminant testing and mushroom potency guarantees.A public lot-report lookup and named performing laboratory were not established in the reviewed sources. Manufacturer guarantees and NASC auditing do not independently verify individual lot results.The homepage describes the company’s own GMP-compliant Texas plant and direct sourcing. NASC independently confirms audited Quality Seal eligibility.Texas is a state-level disclosure, not an exact facility/certificate binding. Shipping origins do not establish manufacturing locations.Many product descriptions use support framing and labels provide cautions.Several reviewed surfaces overreach, including Safe-Sea’s general comparison, Oral Probiotics’ no-brushing/timeline language, Yeast Guard’s side-effect assurance and a homepage drug-replacement testimonial.Current product pages link numerical label galleries and directions; homepage tabs describe quality/testing and public story/FAQ links provide further detail.Information remains distributed. Test results require contact, and study traceability is incomplete; no consolidated public evidence-and-lot-report hub was established.Evidence and editorial review November 13, 2026Sources: 56 declared source records; 22 standalone oral formulas/foods + one bundleIn-depth Four Leaf Rover review →12
Four Leaf RoverLegal manufacturer not established in this scoped review74.5/100 following a finite November 13, 2026 reassessment. Current official galleries disclose numerical labels, Dr Patricia Jordan DVM is named as a formulator, and NASC confi...
13Rank74/100as of 2026-06-13Solid With Gaps13Rank
Front of the Pack
DJP Ventures LLC (operating as Front of the Pack)
Los Angeles, CA74/100as of 2026-06-13Solid With GapsFront of the Pack pairs full per-active mg labeling on both supplements with an unusually well-cited ingredient-evidence catalog and a named, credentialed Chief Science Officer. The gaps are concentrated: finished-product testing is asserted but unverifiable (no named lab, no COA, no lot lookup), the manufacturing facility is held at 'Made in the USA', and 'clinically proven' marketing is applied at the formula level while the underlying studies are ingredient-level.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWhat's in it
- Full per-active milligram disclosure with no proprietary blends across both current SKUs — The One names all twelve actives with amounts and inactives, and Soothe names all five.
- Public ingredient-evidence catalog citing studies with author lists, journals, years, study-design flags, and working links, each labelled as a dog, human, or review study.
- One fully credentialed named expert, Dr. Jamie Peyton (DVM, DACVECC, CVA, CVC, CCRT), surfaced as Chief Science Officer with a dedicated bio page and verifiable qualifications.
What's not in it
- No finished-product testing transparency: no named laboratory, no certificate of analysis, and no lot- or batch-level lookup — only an unquantified 'under the microscope eight separate times' claim.
- The home and Soothe pages disclose Utah manufacturing, but do not name the manufacturing facility or its quality-system certifier.
- The linked research catalog presents ingredient-level studies; no finished-formula trial was identified there. Broad product-outcome framing remains on the home and Ingredients pages.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsDisclosure is near-complete and consistent across the current supplement line, which comprises two SKUs. The One publishes a 'Typical values per scoop' panel naming all twelve actives with per-active milligram amounts (krill 575mg, SunFiber guar gum 525mg, glucosamine 250mg, chondroitin 100mg, OptiMSM 100mg, taurine 100mg, curcumin phytosome 60mg, L-carnitine 50mg, BPL1 postbiotic 25mg, green tea extract 40mg, Sensoril ashwagandha 30mg, Suntheanine L-theanine 25mg), with serving size (~2g/scoop), a weight-based serving guide, a macronutrient table, and a named inactive-ingredients line. Soothe similarly discloses all five actives with per-active mg (MEG-3 fish oil 580mg, TruMune 250mg, Epicor 100mg, BiovaPlex egg membrane 50mg, Floradapt L. sakei 20mg). There are no proprietary blends and no grouped amounts anywhere in the line, and branded raw-material identifiers are named for nearly every active.Two details hold this just below a clean 10: amounts are presented as 'typical values per scoop' rather than guaranteed label minimums with %DV in a formal Supplement Facts format, and Soothe's panel does not surface a separate inactive-ingredients line the way The One does. Publishing guaranteed minimums and a parallel inactives line on Soothe would close the gap.Certified organic brown kelp (Ascophyllum nodosum), sea buckthorn (Hippophae rhamnoides [fruit]), silicon dioxide mineral source [stabilizer/carrier for L-carnitine].The brand publishes ingredient rationale for both products and an explicit five-pillar selection framework on the Ingredients page (Clinically Proven, Pharma Purity, Canine-Centric, Consistency, Human-Grade), and groups actives by the body system they target (Active Body, Healthy Gut, Balanced Mind). Each active carries a short mechanism or role statement — for example, curcumin is described as operating 'as an antioxidant, defending against cellular damage and blocking the enzymes that cause inflammation', L-theanine as triggering serotonin and dopamine while 'stimulating calming alpha waves in the brain', and SunFiber as fermenting 'into short-chain fatty acids that help to cultivate good bacteria in the gut'. Most meaningful actives therefore have a stated biological role, and the Ingredients hub adds supplier-grade and absorption rationale per ingredient. Mechanism depth is uneven, however: several blurbs (ashwagandha, taurine) read closer to benefit lists than to mechanism, and each role statement is a single sentence.The rationale is broad rather than deep — one sentence per active, with some actives described in benefit language rather than mechanism, and no criterion-by-criterion mechanism write-up tied inline to the cited study for every ingredient. Expanding each active to a fuller mechanism paragraph and linking it directly to its citation would lift this toward 9-10.Curcumin operates as an antioxidant, defending against cellular damage and blocking the enzymes that cause inflammation in the body.The home and Soothe pages explicitly qualify clinical wording as ingredient-level; the research catalog identifies study species and design. This corrects the prior unqualified-formula-proof premise.The reviewed pages qualify clinical claims as ingredient-level but do not explicitly state the status of finished-formula trials. Citation disclosure supports tier 9; tier 10’s explicit study-status requirement is not met.Our experts have assembled a catalog of 466 research publications verifying the health claims of our ingredientsThe brand surfaces one fully credentialed named expert: Dr. Jamie Peyton, DVM, DACVECC, CVA, CVC, CCRT, identified as 'Chief Science Officer & Science Advisory Board Chair'. She is named with full post-nominals and a quote on the home page and the Ingredients page, and has a dedicated bio page listing her UC Davis emergency/critical-care residency, her ACVECC mentorship at Four Seasons Animal Hospital, and her 2019 UC Davis Chancellor's Innovation Award. This is substantive, verifiable veterinary disclosure rather than a placeholder. Two factors temper it: the expert is not reachable from primary navigation (there is no Experts or Team link; the dedicated page is found via a /experts redirect), and the About page — the natural team destination — describes only 'A team of vets, biochemists and dog lovers' without naming anyone. The 'Science Advisory Board' that Dr. Peyton chairs lists no other members anywhere on the site.The score is held below 9-10 because the named expert is not surfaced from primary navigation and the About page anonymizes the team, and because the referenced advisory board has no other named members or roster. Linking the expert from the main nav, naming the rest of the board with credentials, and articulating each person's specific role would raise this.Chief Science Officer & Science Advisory Board ChairFinished-product testing is asserted but not substantiated for buyers. The strongest statement is on the /info product pages: 'By putting all of our ingredients under the microscope not once, not twice, but eight separate times…' — an unquantified quality-control claim. No third-party laboratory is named anywhere on the site, no certificate of analysis or potency report is published, and there is no lot- or batch-level lookup tied to a specific bottle. Probing returned 404 for /testing, /quality, /lab-results, /third-party-testing, /coa, and /certificate-of-analysis, and a cross-page scan found no contaminant or microbial panel and no facility testing detail; the only GMP reference on the site belongs to the OptiMSM raw-material supplier, not to FOTP's finished products. The home-page badges ('Pesticide-free', 'Non-GMO') are unsourced brand statements rather than published test results.The brand asserts testing but names no laboratory, surfaces no COA, and connects no testing to specific batches, which caps it at this tier. Publishing finished-product COAs with a named lab, a contaminant/microbial/potency panel, and a lot-linked lookup would move this up several tiers.By putting all of our ingredients under the microscope not once, not twice, but eight separate times, we're hoping to raise the standards of quality control on the pet supplement industry. Once and for all.Current home and Soothe pages identify Utah manufacturing. No manufacturing facility or facility-level quality-system certifier was identified on the reviewed pages.Utah is disclosed, but the manufacturing facility and a facility-level quality system remain unidentified on the reviewed pages. State-level location alone does not meet the tier8 quality-system requirement.The only MSC (Marine Stewardship Council) certified krill in the world, guaranteeing sustainable harvesting and traceability from the exact catch locationClinical wording refers to ingredients. Broader home/Ingredients claims include results in 4–6 weeks, the only daily supplement a dog will need and unrivaled health benefits; C7 remains 7.Broad outcome framing remains; the ingredient qualifier itself is not the deduction.Try The One (and only) supplement with ingredients clinically proven to elevate your dog's whole-body health.Of the four trust pillars, the science pillar is the most navigable: 'Ingredients' sits in the primary navigation, and the full evidence catalog with authors, journals, and study links is one step further at /ingredients/evidence — genuinely strong, inspectable, pre-purchase evidence. The other pillars are harder to reach or thin. The named expert, Dr. Jamie Peyton, is quoted on the home and Ingredients pages but her credentialed bio page is not linked from primary navigation and the About page anonymizes the team. Testing has no destination page (only the unquantified 'eight separate times' line buried on the /info product pages), and manufacturing is a single home-page badge — so two pillars cannot be inspected in three clicks. There is no consolidated trust hub tying science, testing, experts, and manufacturing together.Science is easy to reach, but the expert page is outside primary navigation, the About page is anonymous, and testing and manufacturing lack any findable destination, so a buyer cannot inspect all four pillars in three clicks. A consolidated trust hub plus nav links to the expert and a testing page would raise this.Most dog supplements rely on generic ingredients and anecdotal claims. We're taking the opposite approach, to guarantee that all of our ingredients are backed by verifiable research publications.C3 corrected November 14, 2026; other criterion values retain June 13, 2026Sources: 12 sources reviewedIn-depth Front of the Pack review →13
Front of the PackDJP Ventures LLC (operating as Front of the Pack)Front of the Pack pairs full per-active mg labeling on both supplements with an unusually well-cited ingredient-evidence catalog and a named, credentialed Chief Science Officer....
14Rank72.0/100as of 2026-11-14Solid With Gaps14Rank
Bernie's Perfect Poop
Bernie's Best, Inc.
Austin, Texas, United States72.0/100as of 2026-11-14Solid With GapsBernie’s publishes useful product quantities, research summaries, expert biographies and quality-program details. Grouped amounts, conflicting public versions, partial expert identity and limited public lot evidence remain. The 72.0/100 score measures public disclosure, not safety, efficacy or potency.
Public Evidence System Named ExpertsIngredient RationaleDisease-Claim-FreeNASC Quality Seal Clinical Evidence Published Made In USAWhat's in it
- Substantial serving-based quantities on the digestive, joint and omega products, with explicit distinctions between amounts and nutrient guarantees.
- A captured research library of 24 unique entries, with useful study limitations in sampled summaries; not every paper was independently audited.
- Public first-name R&D and educational biographies disclose roles, qualifications and institutions.
- A quality FAQ describes supplier COAs, pathogen/heavy-metal tests, nutritional analysis, US production and SQF/GMP systems.
What's not in it
- Probiotic CFU and enzyme totals are grouped; dental-treat and oil disclosures do not quantify every preparation. Public package and HTML versions sometimes disagree.
- Some research context is dispersed and one K-State citation target is wrong; the correct thesis does not establish a retail-formula trial.
- Inspected expert biographies use first names. Surname-level identity, per-formula involvement and independently checked qualifications are not established here.
- No named performing analytical laboratory or public finished-product lot report was located in this finite source set. This is not evidence that testing is absent.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsSubstantial quantities appear across the flagship, joint and omega panels. Grouped probiotic/enzyme totals, dental-treat analysis and conflicting product versions prevent a fully quantified-line conclusion.Combined probiotic/enzyme totals, secondary ingredients and current package/HTML conflicts prevent a fully quantified-line conclusion. No exact current recipe is inferred from conflicting versions.Fiber, bacterial spores, prebiotics, enzymes and omega explanations deserve credit. Some other product language relies on broad benefits; a complete ingredient-by-ingredient rationale census was not established.Some product copy uses broad benefit language. The finite six-family review does not establish a complete active-by-active rationale census or clinical efficacy.The captured library lists 24 unique research entries, with useful limitations in sampled summaries. Citation work is dispersed, one repository target is wrong, and exact retail-formula trial status is not established for every family.Not all 24 papers were independently audited. One repository target is wrong, and exact retail-formula study status is not established for every family; this does not make the underlying ingredient research nonexistent.The company provides first names, qualifications, institutions and R&D/education roles. Surname-level identification and per-formula involvement remain incomplete in the inspected biographies.Inspected biographies use first names; surname-level identity and per-formula involvement remain incomplete. Neither expert is presented here as a veterinarian or independently verified degree holder.The quality FAQ describes supplier COAs, contaminant testing and nutritional analysis. No named performing laboratory or public finished-product lot report was located in the declared sources.No named performing laboratory, public finished-product lot report or buyer lot lookup was located in the declared sources. Supplier COAs and program statements do not prove every finished-product lot.US production, SQF/GMP systems and some sourcing are described. Facility identity and independently checked certificate scope were not established; these are attributed company statements.Quality systems are attributed company statements. No facility-level identity or independently checked current certificate scope was established; spelling variations are not additional certifications.Study limitations, risk summaries and veterinary context are useful. Broader bioactivity and joint comparisons, plus the oil comparator-footnote mismatch, still require more precise support.Joint and formula-wide comparisons, broad bioactivity language and the oil comparator footnote need narrower context. This is not a finding of deceptive intent, unlawful conduct or product ineffectiveness.Product information, expert biographies and research are reachable. The detailed quality FAQ needs deeper navigation; the inspected record did not establish one consolidated four-pillar trust hub.Testing/manufacturing details use a deeper knowledge-base route. This is one observed route, not proof no shorter path exists, and no temporary tool failure is treated as a buyer barrier.Evidence and editorial review November 14, 2026Sources: 35 public reference destinations: 33 article sources plus two corporate policy pages; seven inspected images across six families, not 35 studies or an all-variant censusIn-depth Bernie's Perfect Poop review →14
Bernie's Perfect PoopBernie's Best, Inc.Bernie’s publishes useful product quantities, research summaries, expert biographies and quality-program details. Grouped amounts, conflicting public versions, partial expert id...
15Rank71.5/100as of 2026-11-13Solid With Gaps15Rank
Only Natural Pet
Legal manufacturer not established in this scoped review
Pet supplements71.5/100as of 2026-11-13Solid With GapsOnly Natural Pet discloses quantitative labels, a named veterinary advisor, real ingredient citations and public hemp lot reports. Pooled amounts, conflicting panel versions, partial testing coverage and unlinked clinical assurances remain limitations.
Public Evidence System Named Veterinary AdvisorIngredient ReferencesDisease-Claim-FreePublic Hemp Lot ReportsSample Hemp Lot IdentifiedNASC Audited Listing Clinical Evidence Published Made In USAWhat's in it
- Quantitative labels across 12 oral product families
- Named veterinary advisor and real ingredient references
- Public hemp lot reports naming Eurofins and separate manufacturer results
What's not in it
- Pooled ingredients and conflicting current web/gallery versions
- Historical hemp results do not cover every formula or lot
- Specific clinical-proof and broad certainty claims lack linked support
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsThe declared 12-family oral sample provides serving bases and quantitative tables across oils, chews, powders and capsules. Joint, hairball, urinary and calming examples disclose individual preparation amounts; the two multivitamin families add nutrient and enzyme declarations. Most sampled families offer meaningful dose information.The two digestive products pool their principal microorganisms; multivitamins also pool secondary microorganisms. Current HTML and gallery images conflict on the oil formula, Daily Multi quantities and the herbal calming chew mass. The Gut HTML footnote conflicts with its own CFU table and label image. Botanical preparation weights, fatty-acid subcomponents and salt forms are not interchangeable with standardized active masses. These limits prevent near-complete or every-active claims.The Gut page explains enzyme roles in breaking down starches, fats, protein and cellulose, and the antibiotic/probiotic article discusses microbial balance. Joint and urinary pages connect selected ingredients to tissue, fatty-acid or anti-adhesion roles. This is substantive public rationale in parts of the range.The level of explanation varies. Many meaningful ingredients are presented mainly as expected benefits; the Kidney page also contains traditional Chinese medicine concepts that are not treated as verified mechanisms here. Disclosure of a proposed role does not demonstrate the advertised effect, preparation or dose.The education library contains real citation work: the named veterinarian’s taurine article lists journal references, and the mushroom article links a PubMed record and a University of Pennsylvania research announcement. The previous blanket claim that citations appear nowhere is unsupportable.A separate brand-owned Probiotic Blend campaign explicitly claims “Clinically Proven Energy Enhancement” without identifying the supporting product study in that captured page. The sampled formula pages did not supply a verifiable finished-formula study for that assurance. General nutrition or mushroom references cannot establish the current probiotic formula’s clinical result. Tier 4 addresses this specific unsupported clinical-style assurance; it does not claim the brand has no research or that ingredient evidence has been dishonestly borrowed.The About page says the company works with Dr. Jean Hofve to formulate products; her dedicated biography identifies a DVM from Colorado State University in 1994, a holistic veterinary advisor role and professional background. Her name also appears on educational articles. The biography is linked from the About route accessible in primary navigation.These are company-published credentials and roles. The biography states that she retired from active practice and describes Colorado licensure, but this review does not independently verify current license status. Broad formulation involvement does not identify her work on every individual SKU, and generic holistic-veterinarian wording on products is not a formula-specific attribution.The public hemp results hub provides product/dose-form links and lot documents. The inspected composite lot 3320167 includes a Uckele manufacturer microbial COA and Eurofins report 4746113-0 dated December 18, 2024, with cannabinoid, metal, residual-solvent and pesticide results. This is named, lot-linked testing evidence.The hub displays ten product/dose-form labels, not a verified current whole-line SKU denominator. The sampled report covers one historical full-spectrum hemp chew lot; its four microbial PASS results are on the manufacturer page, not the Eurofins report. No every-batch, whole-line potency, clinical-effectiveness or general safety conclusion follows. Access and coverage remain partial.NASC’s public supplier entry names Only Natural Pet and states that the supplier has passed a quality audit and may display its Quality Seal. The brand explains its NASC participation and sourcing approach, while sampled labels identify US manufacture or origin. The inspected hemp certificate separately identifies Uckele in Blissfield, Michigan.NASC participation is a quality-program disclosure, not approval of every product’s efficacy or a laboratory certification. The one Uckele document does not identify the manufacturing network for all twelve sampled families. Facility-specific certifications and traceability across the whole line were not established by these sources. B Corp language is not treated as a supplement testing certification.Many sampled pages use support-oriented language and include directions, cautions and veterinary-consultation statements. The range has real quantitative labels, an identified advisor and public testing documents that should receive credit.The own-brand Probiotic campaign combines a clinical-proof heading with high-certainty language about chronic digestive problems and skin issues. The oil page promises a noticeable coat improvement for any animal, and urinary pages make broad crystal or pathogen-related claims without a matching formula study in the inspected pages. This is an uneven marketing pattern, not a legal conclusion or a finding that the products are ineffective. Source-version conflicts further limit what buyers can confidently verify.Buyers can inspect product tables and images without an account; the About route leads to a named expert biography, and the education library supplies some citations. The hemp hub and its lot PDFs are publicly accessible and searchable.The testing hub was not linked from the inspected home, About or sampled product routes, so reaching the evidence may take dedicated search. This is a bounded navigation finding, not proof that no page links to it or that only a sitemap can reveal it. Evidence is split across product, education, supplier and lot-document routes, with no consolidated three-click trust route established.Evidence and editorial review November 13, 2026Sources: 60 declared source records; 12 oral supplement familiesIn-depth Only Natural Pet review →15
Only Natural PetLegal manufacturer not established in this scoped reviewOnly Natural Pet discloses quantitative labels, a named veterinary advisor, real ingredient citations and public hemp lot reports. Pooled amounts, conflicting panel versions, pa...
16Rank71.5/100as of 2026-05-23Solid With Gaps16Rank
Leap Years
Animal Biosciences, Inc.
United States71.5/100as of 2026-05-23Solid With GapsDirect dog-regimen research, named veterinary leadership and quality-system descriptions are reachable from primary navigation. The study used capsules; it is not a trial of the retail flavored chew itself. Active chemical identities, public lot COAs and a named manufacturing facility remain unverified on these reviewed pages.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Quality Seal Finished-Formula Trial Named Mfg FacilityWorth NotingActive Identity Withheld
The brand uses proprietary blends, grouped amounts, or other label conventions that prevent a buyer from reading the per-active dose on at least one product in the line. Distinct from Line Inconsistency — captures the case where actives are hidden, not where products differ.
What's in it
- Published randomized, blinded, placebo-controlled trial of proprietary LY-D6/2 in capsules at NC State, published in Scientific Reports in 2024; the primary 3-month owner-rated cognitive score analysis favored the full-dose group.
- The primary-navigation Our Story biography names Ginny Rentko, VMD/DACVIM, CEO/CVMO, with development scope and professional experience; trial investigators are named separately.
- Disease-treatment claims are avoided; clinical-style language ('Clinically tested,' 'Studied in Dogs') is anchored to a real trial that buyers can read at nature.com, not to a phantom study.
What's not in it
- Active ingredients are not named at the chemical level — the brand discloses 'NAD Booster' (200mg / 600mg) and 'senolytic' as functional categories, confirms the product does not contain NMN, but never tells the buyer which precursor (NR, NAR, NA) or which senolytic compound (fisetin, quercetin, etc.) is in the formula.
- Testing disclosure is generic: no named third-party laboratory, no public COA lookup, no per-lot traceability, no itemized contaminant / microbial / pesticide / potency panel.
- Manufacturing facility is not named at the facility-name / city / state level; sourcing is described as 'globally sourced ingredients' with no named suppliers or countries of origin.
Why this score— —Why this scoreWhat's missingBrand's own words16
Leap YearsAnimal Biosciences, Inc.Direct dog-regimen research, named veterinary leadership and quality-system descriptions are reachable from primary navigation. The study used capsules; it is not a trial of the...Active Identity Withheld
17Rank71/100as of 2026-11-11Solid With Gaps17Rank
Pet Naturals
FoodScience, LLC
Williston, Vermont71/100as of 2026-11-11Solid With GapsQuantified sample panels, historical named experts and public testing-program detail; current formula roles, relevant study trails and public lot reports remain limited.
Public Evidence System Historical Named ExpertsIngredient RationaleDisease-Claim-FreeNASC Audited Listing Clinical Evidence Published Made In USAWhat's in it
- Numerical panels and serving bases across the 13-product sample
- Named historical veterinarian and product developers on the company’s own blog
- Public parent/brand quality details and independently corroborated NASC audited listing
What's not in it
- Proprietary biopeptide composition and strain identity remain incomplete
- Named roles and reported rabbit testing are historical and concern a discontinued line
- No named analytical lab or public lot-report route located in the reviewed sources
- Corporate testing details are not mapped to every sampled SKU
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsThe 13-product sample publishes numerical panels with serving bases. Hip+Joint uses two chews; Breath Bites separates spirulina mass from chlorophyll yield.Calming retains a 5 mg biopeptide blend; probiotic strain IDs and Skin+Coat EPA/DHA amounts remain unspecified. Daily Probiotic has inconsistent serving/calorie figures.Ingredient glossary and product pages explain roles and some mechanisms.Much detail is brief or scattered; UT Support’s glucosamine HCl joint tile differs from its N-acetylglucosamine urinary panel.General research links and a 2013 informal 14-rabbit account exist.No matched study trail for the 13 current products was established. The rabbit line is discontinued; inaccessible retail-guide content remains unknown.A 2013 article names Jack Landess, DVM, review-board and rabbit-formula roles; a 2014 article names two product developers.Historical disclosures reached through older blog posts do not establish current employment or authorship of present dog/cat formulas.The brand publicly describes ingredient/product third-party testing and NASC sampling; parent pages add testing-method detail.No named analytical laboratory or public lot-report route was located. Group/custom-manufacturing methods are not mapped to every SKU.The brand discloses Vermont manufacturing and SQF/cGMP/NASC systems; NASC’s directory corroborates FoodScience’s audited-supplement listing.No exact factory/city mapping for each sampled product was established. Audits and registrations are not product or efficacy approval.Most sampled copy uses support language and occasional-symptom limits, with dose-combination and veterinary cautions.Some broad effectiveness, immune and all-ages statements exceed matched public support; this is not a finding that the products are unsafe.Panels and ingredient/quality information are accessible; footer and connected parent pages add supporting material.Expert history requires older-blog navigation; no unified current research/lot-report hub was established. Failed guide access is not evidence of absence.Editorial review November 12, 2026; evidence November 11Sources: 32 primary source records; declared 13-product sampleIn-depth Pet Naturals review →17
Pet NaturalsFoodScience, LLCQuantified sample panels, historical named experts and public testing-program detail; current formula roles, relevant study trails and public lot reports remain limited.
18Rank71.0/100as of 2026-11-14Solid With Gaps18Rank
Finn
Finn Wellness, LLC
New York, NY71.0/100as of 2026-11-14Solid With GapsFinn publishes substantial dose information, readable ingredient research and specific soft-chew testing details. Grouped amounts, public version conflicts, formula-specific expert roles and current lot reports remain the useful checks.
Public Evidence System Named DVM EndorsersIngredient RationaleDisease-Claim-FreePublic Lab AccessBatch-Code TraceabilityNASC Participant Clinical Evidence Published Made In USAWhat's in it
- Inspected panels across ten oral product families provide substantial quantities, including seven Calming Aid actives per 2.5 g chew and nine Hip & Joint actives per 3.5 g chew. Units include mass, pooled CFU and enzyme activity.
- Current manufacturer educational articles link readable primary studies and qualify several study designs. The colostrum article distinguishes cell culture from dog trials; the storm article identifies an open-label L-theanine study.
- Finn describes soft-chew batch testing for Salmonella, Listeria and Enterobacteriaceae, with lot codes tracing suppliers, shifts, testing and processing. Its September 28 article separately calls Digestive Probiotics third-party tested.
- The help center attributes soft-chew production to a US cGMP-compliant, SQF-certified facility. NASC separately lists Finn as a supplier participant.
What's not in it
- Microorganisms and some blends remain pooled. The Multivitamin gallery says vitamin B12 5 mg while the modal says 5 mcg; some gallery serving charts have four bands while FAQs have three. Match the actual package before calculating intake.
- Citations remain dispersed and require attention to ingredient preparation, dose, species and endpoint. Selected source inspection did not establish finished Finn formula trials or complete support for the brand’s claims.
- Named placements are endorsements; formula-specific development responsibilities remain unestablished. Some sources spell the third endorser Farren Billand and gallery artwork says Farren Billiard.
- No named performing laboratory, current product-specific lot report or buyer lot lookup was located in the selected sources. NASC audit/seal evidence does not verify those particular analytical tests.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsInspected panels across ten oral product families provide substantial quantities, including seven Calming Aid actives per 2.5 g chew and nine Hip & Joint actives per 3.5 g chew. Units include mass, pooled CFU and enzyme activity.Microorganisms and some blends remain pooled. The Multivitamin gallery says vitamin B12 5 mg while the modal says 5 mcg; some gallery serving charts have four bands while FAQs have three. Match the actual package before calculating intake.Eight sampled manufacturer articles explain ingredients including probiotics, colostrum, seaweed and L-theanine, with research links. They were published August–October 2026, after the June assessment.Rationale coverage remains uneven across the sampled products. Ingredient biology does not establish the effects of the finished Finn formulas.Current manufacturer educational articles link readable primary studies and qualify several study designs. The colostrum article distinguishes cell culture from dog trials; the storm article identifies an open-label L-theanine study.Citations remain dispersed and require attention to ingredient preparation, dose, species and endpoint. Selected source inspection did not establish finished Finn formula trials or complete support for the brand’s claims.Finn publicly names DVM endorsers including Dr. Laura Robinson and Dr. Kerri Nelson. Named professional placements remain visible in the manufacturer material.Named placements are endorsements; formula-specific development responsibilities remain unestablished. Some sources spell the third endorser Farren Billand and gallery artwork says Farren Billiard.Finn describes soft-chew batch testing for Salmonella, Listeria and Enterobacteriaceae, with lot codes tracing suppliers, shifts, testing and processing. Its September 28 article separately calls Digestive Probiotics third-party tested.No named performing laboratory, current product-specific lot report or buyer lot lookup was located in the selected sources. NASC audit/seal evidence does not verify those particular analytical tests.The help center attributes soft-chew production to a US cGMP-compliant, SQF-certified facility. NASC separately lists Finn as a supplier participant.Facility identity remains at country level. The soft-chew manufacturing disclosure does not establish each topper or dental product’s manufacturing certification.Qualified support language remains on core products. Current educational articles distinguish several ingredient, cell-culture and clinical study limits.Broad clinical-confidence and timed-outcome claims still need context.The manufacturer has a populated educational blog with research links, plus public manufacturing and testing disclosures in its footer-linked help center.Research and quality information remain distributed across blog and help-center routes rather than a consolidated evidence destination.Assessed November 14, 2026Sources: 33 distinct public reference destinations across ten sampled oral families and research/quality sourcesIn-depth Finn review →18
FinnFinn Wellness, LLCFinn publishes substantial dose information, readable ingredient research and specific soft-chew testing details. Grouped amounts, public version conflicts, formula-specific exp...
19Rank71.0/100as of 2026-07-03Solid With Gaps19Rank
Open Farm
Open Farm Inc.
Toronto, Ontario, Canada71.0/100as of 2026-07-03Solid With GapsOpen Farm publishes traceable ingredient origins, a named food-recipe nutritionist and a Eurofins supplement-lot report. Supplement-specific expert responsibility, broader panel/lot coverage and facility identity remain limits.
Public Evidence System Named Food-Recipe NutritionistIngredient RationaleDisease-Claim-FreePublic Pathogen ReportPer-Lot TraceabilityNASC Participant Finished-Formula Trial Named Mfg FacilityWhat's in it
- The site publishes a prominent lot-code traceability system for ingredient origins and deeper product information.
- A named, credentialed in-house veterinary nutritionist (Dr. Moran Tal-Gavriel, DVM, DVSc, Dip. ECVCN) is disclosed with a described role on the FAQ page.
- Two sampled supplement PDPs (Skin & Coat, Probiotic Chews) both publish quantified guaranteed-analysis values and ingredient-origin details.
- The inspected Skin & Coat lot report names Eurofins for three pathogen results; NASC separately confirms audit and Quality Seal permission.
What's not in it
- Food-recipe responsibility does not identify who developed or reviewed each supplement formula. The additional team is described collectively rather than named individually.
- The July 3 source review did not locate supplement clinical citations or finished-formula trials; those criterion findings and dates are carried forward.
- The supplied report concerns one submitted sample and three pathogen tests, not ingredient potency or every current lot. Its two physical pages end with printed Page 3 of 3. The food-focused FAQ’s microbial/mycotoxin testing statement is separate from this supplement sample. The reviewed sources do not identify the supplement manufacturing facility by name, city and state. NASC participation is not a product-lot assay or a clinical result.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsVerification confirmed quantified guaranteed-analysis panels on both sampled supplement PDPs, not just the flagship. The current Skin & Coat pouch publishes DHA, EPA, vitamin E, biotin, total omega-3/6/9 and proximate guarantees; the web GA omits a separate EPA row. The Probiotic Chews page independently publishes a guaranteed analysis of 2 Billion CFU total microorganisms across seven named species without strain identifiers, plus crude fat, crude fiber, and moisture. The two-product sample does not establish disclosure across the entire supplement range; the July 3 numerical tier is retained.Two sampled supplement SKUs both disclose quantified per-active amounts, but the units are mixed across nutrients and the remaining supplement-line SKUs were not individually verified.The current FAQ names Dr. Moran Tal-Gavriel, BSc, DVM, DVSc, Dip. ECVCN, as the in-house veterinary nutritionist involved in recipe development and formulation decisions. This supplies a named expert, credentials and role, meeting tier 9. The source is about food recipes; the additional scientific team is not individually named.Food-recipe responsibility does not identify who developed or reviewed each supplement formula. The additional team is described collectively rather than named individually.Open Farm publishes lot-code traceability and an exact Skin & Coat lot report identifying Eurofins sample 395-2026-03310219, lot V2501609/26077SCDSG BA5962. The inspected report records Listeria and Salmonella not detected per 25 g and E. coli not detected per 10 g. This is named-laboratory, lot-linked evidence, meeting tier 8 for partial public COA access.The supplied report concerns one submitted sample and three pathogen tests, not ingredient potency or every current lot. Its two physical pages end with printed Page 3 of 3. The food-focused FAQ’s microbial/mycotoxin testing statement is separate from this supplement sample.The FAQ describes manufacturing at country level. NASC independently confirms Open Farm passed a facility audit and earned permission to display its Quality Seal; the current Skin & Coat pouch bears that seal. This supplies a named quality program while facility identity remains at country level, matching tier 8.The reviewed sources do not identify the supplement manufacturing facility by name, city and state. NASC participation is not a product-lot assay or a clinical result.Expert/testing/manufacturing updated November 14, 2026; other criteria July 3, 2026Sources: 16 dated source records; three affected criteria updatedIn-depth Open Farm review →19
Open FarmOpen Farm Inc.Open Farm publishes traceable ingredient origins, a named food-recipe nutritionist and a Eurofins supplement-lot report. Supplement-specific expert responsibility, broader panel...- 20RankG
Glandex
Vetnique Labs LLC
70.5/100as of 2026-11-14 (C4/C5/C6); other criteria dated 2026-07-03Solid With GapsExperts corrected 7→10, testing 4→6 and manufacturing 7→8 on November 14 to credit full named expert roles, the NASC testing programme and stated FDA-registered cGMP USA facility; five other numerical tiers retain the July 3 assessment. Formula-specific powder quantities and the 2018 review are clarified. Testing 6 does not meet the Closed Science threshold.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWhat's in it
- Original Soft Chews list eight quantified actives; the powder panel provides formula-specific quantities and marks vitamins E and C as beef-flavor-only.
- The primary-navigation expert page names original Glandex formulator Dr James Bascharon, DVM and a broader advisory roster with credentials and biographies. Biographies state advisory, development, nutrition and technical roles. NASC confirms the audited programme expressly covering Glandex.
- Ingredient rationale (fiber mechanism, anti-inflammatory pathway, gut-microbiome support) is explained consistently across the entire product line, not just the flagship.
What's not in it
- The sampled product pages repeat generic clinical wording without an identified supporting study. The published 2018 Glandex review reports postmarketing experience without trial methods, sample size or a control group.
- The reviewed materials do not identify a testing laboratory or provide a public lot-linked COA or test-panel results.
- Manufacturing disclosure names FDA registration and cGMP compliance but does not name a facility, city, or state anywhere in the published pages.
Why this score— —Why this scoreWhat's missingBrand's own wordsExperts/testing/manufacturing corrected November 14, 2026; five criteria dated July 3Sources: 19 dated source records; individual evidence dates retainedFull per-criterion evidence: public dataset ↗In-depth Glandex review →20GGlandexVetnique Labs LLCExperts corrected 7→10, testing 4→6 and manufacturing 7→8 on November 14 to credit full named expert roles, the NASC testing programme and stated FDA-registered cGMP USA facilit... - 21RankVD
VitaDog
VitaDog Nutrition Inc.
Dover, Delaware (registered address; manufacturing facility not disclosed)70.5/100as of 2026-07-03Solid With GapsVitaDog has a real editorial-policy spine, a substantive peer-reviewed sources page, named third-party testing, and a named (if country-level-only) manufacturing quality standard — but the badge stack (Vet Reviewed, Clinically Dosed, Public Eurofins COAs) overpromises against the underlying surface. The testing panel is microbiology-only on one SKU, the brand's own 'vet-led advisory board' has no named members while a named outside DVM reviewer has a documented, expressly editorial role, no finished-formula trial exists, and no manufacturing facility is named. Stronger than the median DTC peer on editorial-policy and quality-system scaffolding; weaker than the marketing implies on named-expert substance.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWhat's in it
- Publishes a substantive 41-entry peer-reviewed sources library with PubMed IDs and DOIs, verified in full against the live page (41 PMIDs, 41 PubMed links, 36 DOIs).
- Publishes an editorial policy and a named outside DVM reviewer with explicit qualifications and article-review scope; product formulation and endorsement are excluded from that role.
- Names Eurofins (ISO/IEC 17025:2017) as testing partner and publishes two per-lot COA PDFs, plus names cGMP as its manufacturing quality standard.
What's not in it
- Eurofins COAs cover microbiology only (E. coli, Salmonella, Yeast, Mold) — no heavy metals, no pesticides, no potency on actives disclosed in the published COAs.
- The formulation-side vet-led advisory board remains unnamed. Samantha Zebley’s disclosed outside editorial role does not establish product formulation, evaluation or endorsement.
- No manufacturing facility name, city, or state is disclosed anywhere on the site; disclosure stops at 'US-based facility' plus the named cGMP standard.
Why this score— —Why this scoreWhat's missingBrand's own words21VDVitaDogVitaDog Nutrition Inc.VitaDog has a real editorial-policy spine, a substantive peer-reviewed sources page, named third-party testing, and a named (if country-level-only) manufacturing quality standar...
22Rank69.5/100as of 2026-11-14Disclosure Gaps22Rank
Virbac
Virbac Corporation
Westlake, Texas, United States69.5/100as of 2026-11-14Disclosure GapsVirbac is a sourceable veterinary-channel brand with stronger dental evidence signals than many supplement brands, especially through VOHC, and a named credentialed veterinarian and quality/compliance officer in public leadership bios. The buyer still has to assemble label detail, manufacturing geography, and expert roles from several disconnected public sources, and lot-level testing evidence remains unpublished.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWorth NotingActive Identity Withheld
The brand uses proprietary blends, grouped amounts, or other label conventions that prevent a buyer from reading the per-active dose on at least one product in the line. Distinct from Line Inconsistency — captures the case where actives are hidden, not where products differ.
What's in it
- VOHC acceptance gives the C.E.T. dental line a buyer-visible external dental-claim signal, and one veterinary product page publishes a 4-item numbered study reference list.
- Public pages disclose headquarters, a St. Louis-area manufacturing facility, and a named Vice President whose role covers FDA and worldwide GMP compliance.
- A named, fully-credentialed veterinarian (Dr. Alan Taylor, holding a Bachelor's degree in Veterinary Medicine and Surgery from the University of Glasgow) is surfaced in primary navigation, though not tied to the C.E.T. line by name.
What's not in it
- Full active-by-active amounts are not consistently published on official product pages.
- No buyer-facing lot-level COA lookup or named laboratory panel was surfaced despite dedicated sitemap and common-handle probing.
- The named veterinarian's and quality officer's disclosed scope covers Virbac North America broadly, not the C.E.T. supplement or dental line specifically, and one product page's footnote citation numbering does not resolve to its reference list.
Why this score— —Why this scoreWhat's missingBrand's own words22
VirbacVirbac CorporationVirbac is a sourceable veterinary-channel brand with stronger dental evidence signals than many supplement brands, especially through VOHC, and a named credentialed veterinarian...Active Identity Withheld
23Rank69/100as of 2026-07-03Disclosure Gaps23Rank
Nordic Naturals Pet
Nordic Naturals, Inc.
Watsonville, California, United States69/100as of 2026-07-03Disclosure GapsNordic Naturals Pet gives buyers a public testing and quality trail centered on a lot-linked COA pathway, a named Norway manufacturing facility (Nordic Pharma), an NASC-audited facility relationship, and fish-oil sourcing certifications. A second production step (Southern California bottling/encapsulation) and an NSF-specific facility certification are disclosed but remain single-sourced without independent corroboration. Current expert roles, complete official-page text labels for the soft-chew line, pet-specific sample COAs, and named testing laboratories are not all surfaced from a buyer-verifiable hub.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWhat's in it
- The Nordic Promise and product pages give buyers a lot-linked COA pathway with potency, purity, and freshness framing.
- Nordic Naturals names its primary fish-oil manufacturing facility (Nordic Pharma, Tromso, Norway) on its own site and has passed an independent NASC facility audit with Quality Seal permission, alongside Friend of the Sea and third-party non-GMO sourcing certifications.
- The pet microsite and Q&A PDF provide omega-3 rationale, a named veterinary nutrition author, and study citations, though the citation set and author byline are dated to 2010.
What's not in it
- The named veterinary nutrition expert is surfaced only in a 2010-dated educational PDF and does not appear on any current (2026) Nordic Naturals pet page checked.
- The official joint, skin, and digestive soft-chew product pages do not publish numeric supplement-facts or guaranteed-analysis panels in accessible text; the per-mg figures are reachable only via a third-party retailer page.
- Current product pages use research-backed phrasing without linking each claim to finished-formula study metadata, and no third-party testing laboratory or NSF-specific facility certification is independently corroborated on any reachable page.
Why this score— —Why this scoreWhat's missingBrand's own words23
Nordic Naturals PetNordic Naturals, Inc.Nordic Naturals Pet gives buyers a public testing and quality trail centered on a lot-linked COA pathway, a named Norway manufacturing facility (Nordic Pharma), an NASC-audited ...- 24RankNV
NaturVet
Garmon Corp. (operating as NaturVet); subsidiary of Swedencare AB
Temecula, California69/100as of 2026-11-11Disclosure GapsQuantified sample panels, detailed quality disclosures and named veterinary roles; grouped amounts, study detail and current formulation scope remain limited.
Public Evidence System Named Veterinary RolesIngredient RationaleDisease-Claim-FreeNASC Audited Listing Clinical Evidence Published Named Temecula ManufacturingWhat's in it
- Quantified panels across the declared sample
- Detailed public manufacturing, sourcing and testing descriptions
- Named historical and educational veterinary involvement
What's not in it
- A grouped enzyme blend and one inconsistent published fatty-acid panel
- Joint-study summary without a full public citation in the reviewed sources
- Current formulation roles and lot-linked analytical reports not fully surfaced
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsNine sampled product families publish serving definitions and amounts in mg, IU, mcg, CFU or enzyme units.Joint Care groups six components into 130 mg. Multivitamin fatty-acid mg/percent figures do not reconcile to its 4,968 mg serving; this is a label inconsistency, not measured potency.Product pages and the Doodle brochure explain ingredient roles, including glucosamine, vitamin C and PB6.The fuller explanations are scattered; many descriptions remain benefit summaries. Rationale disclosure does not establish every claimed outcome.Joint Care describes a 70-dog, 25-day placebo comparison and an activity endpoint, with a results-vary qualifier.No authors, journal, full methods or study link were established in the reviewed sources. This remains a manufacturer-reported study, not verified evidence for every formula.A May 2026 announcement names Nina Nardi, DVM, in education; NASC names Pedro Rivera in the founding joint-formula history.Nardi is not identified as a formulator or adviser there. Rivera’s historical role does not establish current work or every-formula authorship.Quality pages describe ingredient quarantine, identity/lab checks, annual rechecks, microbial targets and finished-product verification.No analytical lab or public lot-report route was identified. UL is the facility auditor, not the assay lab; internal traceability is not a buyer lot lookup.Primary-navigation pages identify owned Temecula production, quality systems, sourcing and traceability; NASC corroborates audited Garmon membership.This scores public facility/quality disclosure. Registration is not clinical approval; current audits, suppliers and every batch were not independently inspected.Many pages use support language and cautions; the reported joint-study outcome is qualified.Other surfaces use stronger safety/effectiveness or allergy-relief wording without a matched full study. This evaluates claim support, not product ineffectiveness.Product panels, Story and Quality are in primary navigation; the partner portal is in the footer.The deeper brochure and named-expert material require distributed searches. Public external company releases count; a failed request is not evidence of absence.Evidence reviewed Nov 11, 2026Sources: 16 source records; declared sampleIn-depth NaturVet review →24NVNaturVetGarmon Corp. (operating as NaturVet); subsidiary of Swedencare ABQuantified sample panels, detailed quality disclosures and named veterinary roles; grouped amounts, study detail and current formulation scope remain limited.
25Rank69.0/100as of 2026-11-14Disclosure Gaps25Rank
Zesty Paws
Zesty Paws LLC
United States69.0/100as of 2026-11-14Disclosure GapsUseful individual quantities on sampled labels, a published native-canine probiotic pilot, named veterinary spokespersons and an NASC audit credential. Blends, product-page/package conflicts and uneven study or lot-report detail still need exact-product checks. The 69.0/100 score measures public disclosure, not potency, safety or efficacy.
Public Evidence System Named ExpertsIngredient RationaleDisease-Claim-FreeNASC Member Clinical Evidence Published Made In USAWhat's in it
- Sampled official package images disclose many serving-based amounts; several products retain explicitly identified pooled blends.
- The Native canine-probiotic pilot is published and names its investigators; the professional information describes observational-study limits.
- Dated manufacturer announcements name DVM spokespersons Lindsay Butzer and Ryan Rucker.
- NASC audit identity, GMP statements and USA/Thailand manufacturing exceptions are publicly described.
What's not in it
- Some website ingredient text and package images conflict. These representations cannot be merged into one verified formula; match the exact item.
- The small uncontrolled Native pilot does not establish every retail dose or clinical efficacy; its six-of-seven alpha-diversity finding is not an 86% clinical response rate.
- Public lot lookup is explicitly CBD-scoped. No lot was submitted in this review; the source set does not supply current lot reports for every oral product or prove that internal testing is absent.
- Named spokesperson and study-author roles do not establish a current product-by-product formulation roster.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsMany sampled official panels give individual serving-based quantities, including the flagship 8-in-1 and Healthy Aging carton. Multiple blends remain pooled.The sample is not a catalogue majority. Product-page/package and flavor/version differences must remain separate.Native information explains strain roles; Mobility + Muscle explains carnitine and cartilage-ingredient selection. Rationale depth varies across selected products.A recognizable mechanism or a human ingredient study does not establish the canine effect of the finished formula or dose.The published 11-dog Native pilot and explicit ingredient-study qualifications are meaningful, directly checkable evidence.Small, uncontrolled tolerability findings do not establish finished-formula efficacy across the catalogue; some studied-ingredient assertions need further dose/species context.Dated News entries identify DVM spokespersons Lindsay Butzer and Ryan Rucker; the Native paper names authors and affiliations.These are specific disclosed roles, not a verified current whole-line formulation roster or an independent review of this article.NASC audit identity, GMP descriptions and Native third-party-testing statements are positive program disclosures; a CBD lot lookup is public.No lot was submitted or report retrieved. The reviewed record does not establish named-lab/current-lot report coverage for every oral product.The FAQ states USA production with globally sourced ingredients and separately names Omega Cat Mousse and Digestion Cat Mousse as Thailand-made.Program and country disclosures do not establish a current factory/certificate map for every SKU; historical recall manufacturing is event-specific.Professional Native information acknowledges an observational pilot, and some ingredient claims identify human research. Those qualifications earn credit.Retail Native copy uses rapid-action language and an 86% microbiome claim: the paper reports increased alpha diversity in six of seven sampled dogs, not an 86% clinical response among all 11 dogs. Other broad benefit statements also need product-specific context.Public product, ingredient, FAQ, quality and research pages let buyers inspect substantial detail before purchase.Useful expert-history announcements and CBD evidence require deeper or footer-linked navigation. The reviewed sources did not establish one hub joining labels, expert roles, research and batch evidence. Product-version conflicts remain a separate verification limit.Evidence and editorial review November 14, 2026Sources: 66 public evidence records / 65 unique URLs; 32 selected product pages and 21 inspected images; not a catalogue censusIn-depth Zesty Paws review →25
Zesty PawsZesty Paws LLCUseful individual quantities on sampled labels, a published native-canine probiotic pilot, named veterinary spokespersons and an NASC audit credential. Blends, product-page/pack...
26Rank69/100as of 2026-11-14Disclosure Gaps26Rank
Rx Vitamins for Pets
Rx Vitamins
Oldsmar, FL69/100as of 2026-11-14Disclosure GapsReadable panels, technical references and a historically named formulator; current roles, factory geography and lot reports remain less accessible.
Public Evidence System Named Formulator (2016/2019)Ingredient RationaleDisease-Claim-FreeNASC Audited Listing Clinical Evidence Published Made In USAWhat's in it
- Readable manufacturer nutrient panels for the core sample
- Public technical report with mechanisms and named references
- Historically named credentialed formulator and independently corroborated NASC audit status
What's not in it
- Grouped probiotic amounts and a report species-name inconsistency
- Historical expert records do not establish current roles
- No manufacturing site or public lot-linked analytical report established in the reviewed sources
- Cross-species ingredient research does not establish finished-formula outcomes
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsPublic panels quantify Essentials and MegaFlex actives. Rx Biotic lists 2 billion viable cells plus 100 mg larch per 1/8 tsp.Probiotic amounts are pooled. Technical CFU figures are per gram, not scoop; B. infantis/lactis naming differs between narrative and panel. Species are not strain identifiers.The public Rx Biotic report explains fermentation, short-chain fatty acids, barrier interactions and prebiotic roles; other sources explain joint ingredients.Rationale varies across the sample and sometimes blends biology with product-benefit language. It does not establish current finished-formula efficacy.The 11-page technical report contains identifiable author, journal and year references to ingredient/strain research.Many concern humans, rodents, other organisms or isolated strains. They are not a current veterinary finished-formula trial; citations are thinner for other sampled products.Company material in AAHA 2019 and AAFP 2016 identifies Robert J. Silver with veterinary credentials and a formulation role.These are historical records, not proof of current employment or every-formula authorship. Researcher K. M. Shahani is not automatically the product formulator.NASC confirms Rx Vitamins’ audited participation; its programme requires random independent-lab product testing. The catalogue separately describes raw-material assays.Programme records do not name the lab or provide brand-specific results, full panels or individual product/lot coverage.The catalogue describes NSF-audited facilities; NASC independently corroborates its own quality-system listing.Actual factory country, name, city and state were not established. Oldsmar is a business address; the relocation banner does not prove manufacturing geography.Shopping pages mostly use support language and veterinary guidance; the technical report clearly addresses veterinary professionals.The report also extrapolates disease/adjunctive applications across species. Current comparative probiotic wording lacks a matched trial in the reviewed sources.The public Catalogs page, technical report and client sheets provide readable panels and references without a login.A separate professional portal is restricted; historical expert records require external search. Those limits do not make the existing public PDFs inaccessible.Evidence reviewed Nov 11, 2026Sources: 13 source records; declared sampleIn-depth Rx Vitamins for Pets review →26
Rx Vitamins for PetsRx VitaminsReadable panels, technical references and a historically named formulator; current roles, factory geography and lot reports remain less accessible.
27Rank68.5/100as of 2026-11-11Disclosure Gaps27Rank
Wholistic Pet Organics
68.5/100as of 2026-11-11Disclosure Gaps68.5/100 under the existing brand-disclosure rubric. Quantified labels, public quality systems and accessible company information earn substantial credit; citation presentation, role specificity and mixed dose formats leave defined gaps.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWhat's in it
- Quantitative information exists across all eight sampled products, with explicit differences in completeness.
- Named facility, quality programs, sourcing controls and traceability are publicly described.
- NASC participation has independent directory corroboration; quality and family information are accessible through primary navigation.
What's not in it
- The declared sample covers eight products across six functional/form categories, including both dog and cat Complete. It is representative editorial sampling, not a census of every SKU, horse product or market.
- Current disclosures are scored as current. Historical archives demonstrate specific old errors but do not establish that every new page element existed in May or July.
- The public testing score does not verify laboratory execution, certificate validity, safety, efficacy or every lot.
- Clinical and claim-discipline findings are limited to the specified pages; failed search queries are not evidence of universal absence.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsThe eight-product sample has substantial quantities, with recurring grouped blends and mixed analysis/serving bases.Meaningful disclosure earns credit; whole-food nutrient concentrations are not every ingredient’s input weight.Ingredient roles are explained across nutrition, joint, digestive, immune and oil products; some explanations remain benefit-led.Recognized nutrient/enzyme roles receive credit without requiring a new finished-product trial.Run Free uses therapeutic-style ingredient explanations; the food/supplement page invokes study levels without identifiable study citations.This scores citation presentation in reviewed sources, not whether research exists elsewhere.The family mission identifies relevant founder education and development history, but current scientific roles need interpretation.No requirement for a separate named formulator for every product is imposed.A risk-based third-party testing program and release controls are described; public lot-report access remains limited.NASC audit is credited separately and not recast as a product laboratory report.Own Bedford manufacturing, quality programs, supplier controls and lot traceability are reachable through primary navigation.Full credit is for disclosure; it does not independently certify each registration or operational claim.Normal-support positioning coexists with broad nutrition and therapeutic-style benefit language whose supporting evidence is not surfaced.This is a qualified presentation judgment, not a finding of deception or product ineffectiveness.Quality and family history are accessible through Why Wholistic; ingredient rationale is accessible through product navigation.The evidence is distributed across primary links rather than consolidated into one complete evidence hub.Reviewed November 11, 2026Sources: Dated primary sources; criterion mappings in the datasetIn-depth Wholistic Pet Organics review →27
Wholistic Pet Organics68.5/100 under the existing brand-disclosure rubric. Quantified labels, public quality systems and accessible company information earn substantial credit; citation presentation,...
28Rank68.5/100as of 2026-11-12Disclosure Gaps28Rank
Vet's Best
Compana Pet Brands — public parent-company portfolio
Dog and cat supplements68.5/100as of 2026-11-12Disclosure GapsQuantitative package panels, a named DVM founder and broader NASC/US-manufacture disclosures; current reviewer identities, matched studies and public lot reports remain limited.
Public Evidence System Historical DVM FounderIngredient RationaleDisease-Claim-FreeNASC Audited Listing Clinical Evidence Published Made In USAWhat's in it
- Numerical panels, including quantitative images missed by text-only extraction
- Named credentialed founder and specific historical role in primary-navigation About
- NASC program listing and country-level manufacturing disclosures across multiple formulas
What's not in it
- Several grouped quantities and five HTML panels without an independently verified serving heading
- NASC program participation does not expose specific lot results or a named testing lab
- Historical founder disclosure does not name current reviewers of each supplement
- Some published directions and one joint-panel amount conflict
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsThe 14-formula sample has numerical panels; eight inspected package backs establish serving bases, including Skin & Coat and Multi-Vitamin.Several blends remain grouped; probiotics pool six species. Five HTML headings lack an independently verified serving basis; formulas and daily doses must not be conflated.FAQ explains urinary-pH cautions and other ingredient/use mechanisms; product pages provide physiological roles.Rationale is scattered and often stops at benefits. Dental explanations are brand context, not evidence for the sampled supplement formulas.About provides broad ingredient science, safety and effectiveness assurances, including scientific-proof wording.No matched study trail was established for the 14 formulas in the declared sources. This is not proof that research is absent or the products ineffective.Primary About names founder Dawn Curie Thomas, DVM, with the 1989 origin and early topical-development role.Historical expertise does not name present reviewers, establish current licensing or identify each supplement’s formulator.NASC’s audited-supplement directory and random independent label-claim testing rules provide a meaningful program signal.The sources do not identify tested products/lots, results, a named analytical laboratory or a public lot-report route.Multiple package images disclose US manufacture with US/global ingredients; NASC disclosure extends beyond one dental product.No named factory map was established. Published package photos and business addresses do not verify every current lot’s manufacturing location.FAQ cautions cover supplement combinations and the urinary product’s kidney-related and long-term-use limits.Broad assurance and conflicting urinary/calming directions or joint-panel amounts need clarification; these are documentation findings, not safety conclusions.Product collections, About and FAQs are accessible from primary navigation; package galleries add numerical evidence.Quality/testing detail is split across product and NASC sources. Failed automated requests are access limitations, not missing evidence.Evidence and editorial review November 12, 2026Sources: 32 primary sources; declared 14-formula sampleIn-depth Vet's Best review →28
Vet's BestCompana Pet Brands — public parent-company portfolioQuantitative package panels, a named DVM founder and broader NASC/US-manufacture disclosures; current reviewer identities, matched studies and public lot reports remain limited.- 29RankHP
Honest Paws
Honest Paws, LLC
League City, Texas, United States68/100as of 2026-06-13Disclosure GapsHonest Paws operates one of the few buyer-usable batch-linked COA lookups in the DTC pet CBD segment, with full contaminant panels from a named ISO 17025-accredited laboratory, and publishes exact CBD doses across its hemp line. Disclosure weakens off that flagship line: non-CBD products sit outside the COA tool and several omit per-active amounts, veterinary claims are not tied to named experts, and manufacturing identity stays at country level.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreePublic COA LookupPer-Lot TraceabilityNASC Member Finished-Formula Trial Named Mfg FacilityWhat's in it
- Batch-linked Certificates of Analysis lookup covering 26 CBD product types and 154 batches, serving full-panel PDFs — cannabinoid potency, pesticides, mycotoxins, residual solvents, heavy metals, and microbiology — from SC Laboratories, an ISO 17025-accredited laboratory named on every report.
- CBD-line label disclosure is consistent and exact: every bite, soft chew, and tincture strength publishes hemp-oil mg with naturally occurring CBD mg per serving, plus itemized inactives and weight-banded feeding charts.
- NASC Quality Seal disclosure goes beyond the badge — a dedicated page documents biennial third-party audits, adverse event reporting, a Quality Control Manual, and GMP adherence, and PDPs identify the brand as an audited NASC Primary Supplier Member.
What's not in it
- Veterinary involvement is asserted sitewide ('Vet Recommended', 'Veterinarian-reviewed') but never connected to a named individual; the DVM bios that exist are unlinked team pages that state no formulation, review, or advisory role.
- The non-CBD line discloses materially less than the CBD line: no non-CBD product appears in the COA lookup, the Multivitamin omits vitamin amounts but quantifies selected actives, Fish Oil publishes EPA and DHA percentages, and Probiotics and Turkey Tail hold part of their panels at blend-level totals.
- Manufacturing identity is held at country level — 'USA made' with GMP and NASC language but no facility name, city, or state, and no FDA facility-registration disclosure.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsCBD-line panels remain quantified. The Multivitamin label lists glucosamine 80 mg, chondroitin 55 mg and omega-3s 40 mg per 3 g chew; Fish Oil gives EPA 6%, DHA 5.5% and omega-3s 18% per 4.5 g teaspoon. Vitamin amounts and some other products’ component amounts remain missing.Multivitamin vitamin amounts, individual probiotic counts and Turkey Tail antioxidant-component amounts remain undisclosed; Fish Oil fatty-acid percentages are published.Label quantities and formal expert flag corrected November 14, 2026; criterion values unchangedSources: 20 sources reviewedIn-depth Honest Paws review →29HPHonest PawsHonest Paws, LLCHonest Paws operates one of the few buyer-usable batch-linked COA lookups in the DTC pet CBD segment, with full contaminant panels from a named ISO 17025-accredited laboratory, ...
30Rank68/100as of 2026-07-03Disclosure Gaps30Rank
True Leaf Pet
Trueleaf Petcare Inc.
Vernon, British Columbia, Canada68/100as of 2026-07-03Disclosure GapsNamed veterinary co-founder, active-amount panels and an own plant in Vernon, British Columbia. The ingredient-COA programme remains described rather than publicly accessible; facility certification scope is incomplete.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Quality Seal Finished-Formula Trial Named Mfg FacilityWhat's in it
- A named, fully credentialed co-founder veterinarian (Dr. Daniela Fischer, DVM/MSc/PhD) is disclosed on both the homepage and the primary-nav ingredients page, with a stated role overseeing product formulas.
- Rare hemp honesty — 'Our products don't contain any cannabinoids' — with THC-absence testing stated, external claim review via the Canadian Veterinary Health Product designation, and NASC regulations followed in the US.
- Full per-active mg panels with no proprietary blends were confirmed across five checked SKUs spanning three of the four product families, plus a named own plant in Vernon, British Columbia and named Saskatchewan hemp sourcing.
What's not in it
- The described ingredient-COA program is unpublished: no named lab, no public certificate, no lot access, confirmed across all 15 archived pages and direct handle probes for common COA/quality-page URLs.
- Four of four calming-line product pages checked use unqualified 'clinically studied'/'clinically researched' language with no study, author, or journal surfaced anywhere on the reviewed surfaces.
- The own plant is identified in Vernon, British Columbia, but the reviewed current pages do not publish facility-level cGMP, HACCP, SQF or ISO certification documents.
Why this score— —Why this scoreWhat's missingBrand's own wordsC6 and badge corrected Nov 15, 2026; other criteria Jul 3, 2026Sources: 13 original sources; 3 bounded correction sourcesFull per-criterion evidence: public dataset ↗In-depth True Leaf Pet review →30
True Leaf PetTrueleaf Petcare Inc.Named veterinary co-founder, active-amount panels and an own plant in Vernon, British Columbia. The ingredient-COA programme remains described rather than publicly accessible; f...
31Rank67.5/100as of 2026-11-14Disclosure Gaps31Rank
Tomlyn
Vetoquinol USA, Inc.
67.5/100as of 2026-11-14Disclosure GapsTomlyn publishes quantitative labels across most sampled oral products, named veterinary contributions and an L-lysine citation. NASC corroborates its supplier status; grouped amounts and purchased-lot documentation remain the practical gaps.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWhat's in it
- All four current Nutri-Cal galleries link quantitative Guaranteed Analysis panels per teaspoon (6 g); other sampled oral ranges also print active amounts.
- Historical company interviews name Dr. Jim Lowe and Dr. Jim Spiezio; Spiezio credits specific product-development work. L-lysine pages publish an identifiable ingredient-study citation.
- NASC’s own supplier listing corroborates audited status and seal permission. Current labels disclose Canada or USA manufacture, depending on the product.
What's not in it
- Pre & Probiotic and Dermal Soothe retain major pooled or preparation-level quantities.
- NASC participation includes a random independent-product-testing requirement, but no named analytical laboratory or purchased-lot result is identified by the reviewed programme records.
- The named expert biographies are historical and do not establish current formulation responsibility for every product. Specific manufacturing facility/city and site-certification scope remain unestablished by the selected sources.
Why this score— —Why this scoreWhat's missingBrand's own wordsLabels/manufacturing updated Nov 14, 2026; six criteria retainedSources: 23 sources for targeted update; prior evidence retainedFull per-criterion evidence: public dataset ↗In-depth Tomlyn review →31
TomlynVetoquinol USA, Inc.Tomlyn publishes quantitative labels across most sampled oral products, named veterinary contributions and an L-lysine citation. NASC corroborates its supplier status; grouped a...
32Rank67/100as of 2026-11-11Disclosure Gaps32Rank
Pet Wellbeing
Louisville, KY, USA67/100as of 2026-11-11Disclosure GapsNamed experts, real ingredient research and detailed testing claims; grouped herb doses and strong clinical extrapolation remain concerns.
Public Evidence System Named ExpertsIngredient RationaleDisease-Claim-FreeNASC Audited Listing Clinical Evidence Published Made In USAWorth NotingGrouped Active Amounts
Ingredient identities are listed; grouped amounts prevent reading each constituent’s dose.
What's in it
- Named veterinary formulators and advisors with credentials and roles
- Identifiable ingredient research and detailed biological explanations
- Public testing-method descriptions, US quality-system statements and NASC audit signal
What's not in it
- Life Gold and Kidney Support Gold publish blend totals rather than each herb’s amount
- No public lot-linked analytical report or named testing laboratory located in the reviewed sources
- Uneven separation of ingredient studies from finished-formula outcomes, plus a Milk Thistle herb-total/silymarin inconsistency
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsLife Gold lists six herbs totaling 312 mg/mL; Kidney Support Gold lists four totaling 400 mg/mL. Milk Thistle lists 333 mg/mL herb.Two of three distinct sampled formulas omit individual-herb quantities. Milk Thistle later calls 333 mg/mL active silymarin; that total-herb/constituent conflict is unresolved.Product pages and the Life Gold dossier explain ingredient roles and biological mechanisms with references.Some explanations remain broad support/detox wording; blend ratios and finished-formula outcomes are not established. Mechanism disclosure is credited on its own scope.The Life Gold dossier identifies real journal-attributed ingredient studies, including ginger and Astragalus dog research.Ginger used specific extracts/doses; Astragalus used intravenous polysaccharides in experimental immunosuppression. Neither tested the current oral blend; citations are uneven across products.Expert biographies name Janice Huntingford and Ronald Koh. The Life Gold dossier identifies Patricia Jordan as lead formulator and Mandy Tinevez in R&D.The biography link is in the footer. Some roles are less complete, and involvement in every formula is not inferred.FAQ/product sources describe identity, microbial, pesticide, vitamin/mineral/heavy-metal checks, HPTLC/HPLC and every-batch third-party verification.No named analytical lab or buyer lot-report lookup was located. Internal raw-material COAs and every-batch assurances are not public batch results.FAQ describes US GMP/cGMP facilities, FDA registration and sourcing; NASC independently confirms audited supplement membership.Exact factories and SKU mappings remain unidentified. Mailing address is not factory proof; FDA registration is not product approval.Sources provide real cautions and distinguish customer reviews from medical evidence.Repeated cancer-outcome confidence, broad overdose reassurance, absorption superiority and the herb/silymarin conflict exceed matched public support; this is not a safety verdict.Ordinary product pages disclose doses, rationale and testing; footer links expose expert and FAQ information.The deeper research dossier required targeted discovery. Evidence is distributed rather than in one primary-navigation hub; transport errors are not scored as absence.Evidence reviewed Nov 11, 2026Sources: 11 source records; declared sampleIn-depth Pet Wellbeing review →32
Pet WellbeingNamed experts, real ingredient research and detailed testing claims; grouped herb doses and strong clinical extrapolation remain concerns.Grouped Active Amounts- 33RankSPVF
Standard Process Veterinary Formulas
65.5/100as of 2026-11-11Disclosure GapsPublic product pages provide ingredient information, some active quantities and ingredient references. A public veterinary-team document and detailed manufacturing/testing disclosures also exist. Blend-level quantities and scattered evidence remain real limits.
Public Evidence System Named Experts (2023)Ingredient RationaleDisease-Claim-FreeNASC Quality Seal Clinical Evidence Published Disclosed Production SitesWorth NotingGrouped Active Amounts
The published rubric includes grouped active amounts under this watchout. Ingredient identities are listed; individual amounts are not given for each blend constituent.
What's in it
- Named Palmyra manufacturing campus and owned-farm sourcing disclosures
- Specific in-house raw-material and finished-product testing program
- Public product information and dated named veterinary-support roles
What's not in it
- Proprietary-blend or ingredient-list disclosure dominates the declared sample
- Ingredient references do not establish clinical results for all finished formulas
- The 2023 veterinary-team document is not a current employment confirmation or a formula-authorship record
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsCanine Immune publishes EpiCor33 mg,zinc1 mg,vitamin E0.3 mg,iodine0.03 mg and a290 mg blend per370 mg scoop. Canine Enteric gives a400 mg blend; Feline Enteric a290 mg blend per350 mg tablet. Whole Body publishes an ingredient list and serving directions.The original claim that public panels do not exist is wrong. Nevertheless, individual component quantities are missing within dominant blends, so tier 4 remains appropriate for this four-product sample; public availability and complete quantification are different questions.The immune page supplies zinc/iodine biology references, while enteric and whole-body pages explain general organ/nutrient roles. The public brochure describes organ-tissue and glandular support reasoning.That reasoning does not establish organ-specific clinical benefit for each ingredient or formula. Recognized nutrient mechanisms coexist with broader extrapolations; the sampled rationale does not qualify for the7–10 requirement across the line.Canine Immune publicly lists identifiable scientific references, contradicting the assertion that citations are all practitioner-gated.The references primarily support ingredient biology. Comparable formula-specific citation coverage was not located across the four declared products; the corrected finding is partial/scattered evidence rather than no public evidence.A public veterinary sales/support document dated2023 identifies Nancy Loes,DVM,Veterinary Liaison,and Jody Griffiths,CVT,Veterinary Product Support Specialist, with a stated support role.This is deep-document named expert disclosure. It does not confirm present employment in2026 or name the formulator for every SKU, and it does not satisfy the full primary-navigation biography requirements of 10.The manufacturing page describes the in-house quality laboratory, raw/in-process/finished tests, potency/purity/adulterant checks and analytical methods; it states each batch undergoes multiple tests. This is a specific public testing program.It remains the manufacturer's program description. No buyer-accessible lot-specific report or independent named laboratory for the four sampled products was located in the stated source set; tier8's named-third-party-lab requirement is not established.The Palmyra campus is named at1200 W.Royal Lee Drive, with owned-farm sourcing and public manufacturing/quality-control procedures. The company discloses organic certification for its farming/manufacturing process.Organic farm/process certification is not certification of every veterinary formula as organic. Full per-facility certification scope and complete sourcing traceability are not demonstrated for every sampled product, preventing10.Product pages generally frame digestive, immune and daily-maintenance support and include cautions. Other public material makes broader organ-tissue repair or comprehensive system-support implications.The distinction between nutrient rationale and demonstrated finished-formula outcomes requires buyer interpretation. This evaluates presentation and qualification; it is not a conclusion that products are ineffective or unsafe.Product pages, references and quality information are public without a practitioner login, but finding the dated veterinary-team document and assembling the evidence requires search/deeper documents.Some professional services are account-restricted, but that cannot be generalized to all panels and citations. Automated403 responses are transport failures and were not used as adverse evidence.Evidence reviewed Nov 11, 2026Sources: 8 source records; representative product sampleIn-depth Standard Process Veterinary Formulas review →33SPVFStandard Process Veterinary FormulasPublic product pages provide ingredient information, some active quantities and ingredient references. A public veterinary-team document and detailed manufacturing/testing discl...Grouped Active Amounts
34Rank63.5/100as of 2026-07-03Disclosure Gaps34Rank
Super Snouts
63.5/100as of 2026-07-03Disclosure GapsRebuilt research record for Super Snouts from live-fetched surfaces (2026-07-03): homepage, FAQ, the informatives COA library, product pages, and — added during adversarial verification — a second COA page (Test Results) and an education page (CBD 101) discovered via sitemap and navigation inspection. Every rubric item carries verified evidence, a verbatim quote, gap, and confidence level.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWorth NotingActive Identity Withheld
The brand uses proprietary blends, grouped amounts, or other label conventions that prevent a buyer from reading the per-active dose on at least one product in the line. Distinct from Line Inconsistency — captures the case where actives are hidden, not where products differ.
Unnamed Experts
The brand uses "veterinarian formulated," "expert designed," or similar language without any publicly named individual, credentials, or role.
What's in it
- Public lot-linked hemp-product COAs include inspected reports issued by SC Labs; the Test Results page organizes reports by product category.
- A real, independently-verified safety citation: the informatives page cites a peer-reviewed veterinary toxicology paper (PMID 23796481) to support its non-detectable-THC standard, honestly scoped to the safety claim rather than borrowed for efficacy.
- Single-ingredient transparency at its best: Joint Power is '100% New Zealand Green Lipped Mussel' with weight-based dosing and loading-phase guidance; a dedicated CBD 101 page explains the water-soluble absorption mechanism in structured, buyer-facing terms.
What's not in it
- No named individual anywhere: veterinary direction is attributed to an unnamed supplier expert AND a separately-claimed, unnamed in-house 'Chief Veterinary Officer'; 'Veterinary recommended' badges carry no name either.
- The earlier 8-product review’s dose-gap count is corrected: Joint Power powder and soft chews both quantify 300 mg GLM; five other products retain unresolved per-active disclosure findings.
- The two COA archives cover the CBD/hemp product line only — none of the 8 non-CBD products reviewed for other criteria (Joint Power, Firm Up, G.I. Balance, Lion's Roar, Pumpkin Latte, Super Shrooms) appear in either archive — and the archives are not cross-linked to each other.
Why this score— —Why this scoreWhat's missingBrand's own words34
Super SnoutsRebuilt research record for Super Snouts from live-fetched surfaces (2026-07-03): homepage, FAQ, the informatives COA library, product pages, and — added during adversarial veri...Active Identity WithheldUnnamed Experts
35Rank63.5/100as of 2026-07-03Disclosure Gaps35Rank
The Missing Link
63.5/100as of 2026-07-03Disclosure GapsThe Missing Link has one of the better buyer-facing label paths among the remaining brands, across both powders and chews, and has independently verified audited-parent NASC participation, alongside the earlier FDA facility registration disclosure. Its main gaps are lot-level testing records, clinical citation transparency, and current expert review beyond the founder story.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Audited Listing Finished-Formula Trial Named Mfg FacilityWhat's in it
- Most representative products across powders and chews publish directions, ingredients, and per-active mg amounts.
- The brand publicly names founder and veterinarian Dr. Robert Collette on its About Us page.
- NASC independently lists parent W.F. Young as audited for supplements; the brand identifies the relationship and its Skin & Coat gallery displays the Quality Seal. The earlier FDA-facility-registration disclosure is retained.
What's not in it
- No public COA lookup, named lab, or lot-specific report was found.
- Proof-oriented claims recur across multiple pages without visible study documentation.
- Current expert-review scope beyond the founding story is not mapped to each formula.
Why this score— —Why this scoreWhat's missingBrand's own wordsC5 and label correction Nov 15, 2026; other criteria Jul 3, 2026Sources: 13 original sources; 5 bounded correction sourcesFull per-criterion evidence: public dataset ↗In-depth The Missing Link review →35
The Missing LinkThe Missing Link has one of the better buyer-facing label paths among the remaining brands, across both powders and chews, and has independently verified audited-parent NASC par...
36Rank63/100as of 2026-07-03Disclosure Gaps36Rank
Adored Beast Apothecary
63/100as of 2026-07-03Disclosure GapsVerified transparency record for Adored Beast Apothecary, completed 2026-07-03. All 14 cited sources were fetched and archived; every exact_quote was confirmed verbatim against its cited source; the brand's own site was actively probed for COA, facility, and named-expert pages before any score reflecting an absence was finalized. Named-expert and scientific-rationale evidence are strong and easy to find; testing/COA and manufacturing disclosure are the brand's weakest areas.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWhat's in it
- Founder and formulator Julie Anne Lee, DCH RCSHom is named with full credentials and biographical detail on a page linked directly from the site's primary top-level navigation.
- The flagship Healthy Gut and the Equine and Feline Gut Soothe formulas publish full per-active mg/CFU dose panels rather than a single blended total.
- A dedicated Ingredient Glossary explains a biological mechanism, not just a benefit claim, for most of the roughly 50 actives used across the line.
What's not in it
- The reviewed materials do not provide a public lot-linked COA lookup, named third-party laboratory or test-panel results. The FAQ describes manufacturers serving professionals, not a policy barring retail certificate requests.
- No manufacturing facility name, city, state, or quality-system certification (NASC, cGMP, HACCP, FDA registration, SQF, ISO) is disclosed; the only manufacturing claim found is a country-level "Handcrafted in the USA" banner.
- Several products (Canine Gut Soothe, Gut Soothe, and the Liver Tonic component sold inside both protocol bundles) label part of their formula a proprietary blend with a total CFU or no per-active amount, while the flagship and other SKUs disclose full per-active dosing.
Why this score— —Why this scoreWhat's missingBrand's own wordsC6 contradictory gap wording corrected to credit stated USA manufacture. Tier7 and total 63 unchanged; original factual evidence dates retained.Sources: 15 dated source records; individual evidence dates retainedFull per-criterion evidence: public dataset ↗In-depth Adored Beast Apothecary review →36
Adored Beast ApothecaryVerified transparency record for Adored Beast Apothecary, completed 2026-07-03. All 14 cited sources were fetched and archived; every exact_quote was confirmed verbatim against ...
37Rank63.0/100as of 2026-11-14Disclosure Gaps37Rank
Dinovite
Dinovite / Compana Pet Brands
Compana Pet Brands portfolio63.0/100as of 2026-11-14Disclosure GapsDinovite discloses product quantities and ingredient rationales and names a PhD nutritionist across several product families. Readable ingredient studies and historical official testing records deserve credit. Grouped amounts, incomplete citation links and current lot-report limits remain.
Public Evidence System Named PhD NutritionistIngredient RationaleDisease-Claim-FreeNASC Quality Seal Clinical Evidence Published Made In USAWorth NotingActive Identity Withheld
Published trigger met by C1=6 and ingredient-forward products with pooled/grouped quantities; no intent inference.
Evidence Buried
Published trigger met by C2/C4 at least7 and C8=6; dedicated research and regulator discovery is documented.
What's in it
- Selected manufacturer descriptions disclose nutrient guarantees, enzyme activities, oil fatty-acid percentages and product-specific amounts. The current 29 g dental-chew table gives 250 mg COHP and a 245 mg grouped oral-health blend.
- Three relevant oral-postbiotic papers are publicly readable. The manufacturer attributes studies to the ingredient and distinguishes clinical from in-vitro findings; these qualifications receive credit.
- Dr. Inke Paetau-Robinson is named as a senior R&D nutritionist across core, puppy, dental and liquid product materials. Manufacturer copy identifies a PhD, supported by institutional and professional records.
- Kentucky official reports publish historical 2023 and 2024 manufacturer/guarantor testing under Compana-Manna Pro dba Dinovite LLC. This is identifiable public testing evidence even though it is published independently of the brand.
What's not in it
- Core powders and Meal Booster pool microorganisms and omit some promoted ingredient amounts; dental products contain grouped blends. Tier 6 holds even if all retained descriptions are visible. The retained descriptions do not establish current package equivalence.
- The inspected manufacturer clinical summaries do not identify authors, journals or direct paper links. Independent research was needed to connect the summaries to the papers; current supplier and exact retail-formula identity remain unestablished.
- The historical company records do not identify the current reviewed SKU or lot, establish a brand-operated COA program, or prove current whole-line testing.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsSelected manufacturer descriptions disclose nutrient guarantees, enzyme activities, oil fatty-acid percentages and product-specific amounts. The current 29 g dental-chew table gives 250 mg COHP and a 245 mg grouped oral-health blend.Core powders and Meal Booster pool microorganisms and omit some promoted ingredient amounts; dental products contain grouped blends. Tier 6 holds even if all retained descriptions are visible. The retained descriptions do not establish current package equivalence.The dental article explains oral microbes, volatile sulfur compounds and postbiotic action; cat and oil pages give taurine and fatty-acid rationales. Relevant primary ingredient research exists.Mechanism explanations vary across the ten sampled routes. General ingredient biology does not validate current Dinovite doses or finished formulas.Three relevant oral-postbiotic papers are publicly readable. The manufacturer attributes studies to the ingredient and distinguishes clinical from in-vitro findings; these qualifications receive credit.The inspected manufacturer clinical summaries do not identify authors, journals or direct paper links. Independent research was needed to connect the summaries to the papers; current supplier and exact retail-formula identity remain unestablished.Dr. Inke Paetau-Robinson is named as a senior R&D nutritionist across core, puppy, dental and liquid product materials. Manufacturer copy identifies a PhD, supported by institutional and professional records.A full current biography, each-formula responsibility and the identities of secondary veterinarians remain incomplete. A named PhD nutritionist is not a veterinary-degree claim.Kentucky official reports publish historical 2023 and 2024 manufacturer/guarantor testing under Compana-Manna Pro dba Dinovite LLC. This is identifiable public testing evidence even though it is published independently of the brand.The historical company records do not identify the current reviewed SKU or lot, establish a brand-operated COA program, or prove current whole-line testing.The manufacturer states USA production with domestic and imported ingredients. Compana publicly includes Dinovite in its portfolio; historical official records name a Crittenden, Kentucky company location.Current facility-level identity, certification and certifier scope were not established. Historical company/sampling locations do not establish a currently certified factory.Ingredient-study attribution, in-vitro wording, cat medication/thyroid cautions, introduction instructions and dental adjunct warnings qualify several claims.Uncontextualized immune-health percentages, customer percentages without denominators and a broad dental-powder comparison remain. Ingredient studies do not establish all finished-product or superiority claims.Product information and FAQs are public. Research and official testing records can be found through separate primary sources, rather than being nonexistent.Underlying papers and regulator records require dedicated discovery.Assessed November 14, 2026Sources: 24 unique public reference destinations across ten sampled product routes and external research, professional and historical regulatory sourcesIn-depth Dinovite review →37
DinoviteDinovite / Compana Pet BrandsDinovite discloses product quantities and ingredient rationales and names a PhD nutritionist across several product families. Readable ingredient studies and historical official...Active Identity WithheldEvidence Buried
38Rank63/100as of 2026-07-03Disclosure Gaps38Rank
Grizzly Pet Products
63/100as of 2026-07-03Disclosure GapsGrizzly publishes detailed omega-oil panels and ingredient rationale. NASC independently documents its quality programme, including random product testing; a primary acquisition announcement names historical founder Harald Fisker. Public lot results and current scientific credentials remain unresolved.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWhat's in it
- Every one of the 7 live product pages discloses a complete per-active mg/mcg or Guaranteed Analysis panel with a full inactive-ingredients list and zero proprietary-blend language found anywhere on the site.
- A dedicated, primary-navigation science page explains the biological mechanism and bioavailability differences between Omega-3, -6, and -9 fatty acids, with one externally cited source for a sourcing claim.
- NASC membership and region-level (Alaska) sourcing detail are disclosed on primary pages, though without a named facility address.
- NASC independently confirms Quality Seal approval; its programme includes random independent-laboratory product testing.
What's not in it
- The reviewed materials do not identify the testing laboratory or provide public Grizzly lot results or a lot-linked COA lookup.
- Historical founder Harald Fisker is named, but current scientific credentials and formulation responsibilities are not established.
- The one genuine external citation found on the site supports an environmental-sourcing claim, not a health or efficacy claim, and no finished-formula clinical evidence is disclosed for any product.
Why this score— —Why this scoreWhat's missingBrand's own wordsC4 4→5 and C5 1→6; total 54→63. C8 factual premise corrected with tier 6 retained. Other six numerical criteria keep July 3 evidence dates.Sources: 17 dated source records; individual evidence dates retainedFull per-criterion evidence: public dataset ↗In-depth Grizzly Pet Products review →38
Grizzly Pet ProductsGrizzly publishes detailed omega-oil panels and ingredient rationale. NASC independently documents its quality programme, including random product testing; a primary acquisition...- 39RankPFY
Pawfy
Pawfy Inc.
Raleigh, NC, USA62/100as of 2026-11-15Disclosure GapsPrimary product pages disclose amounts, DVM endorsements and quality claims. Daisy May’s consultant biography is deeper; active NASC seal participation is unverified.
Public Evidence System Named DVM EndorsersIngredient RationaleDisease-Claim-FreeNASC Seal: Unverified Finished-Formula Trial Named Mfg FacilityWhat's in it
- Current panels give serving-based amounts; Probiotic vitamins and organisms remain grouped.
- Daisy May’s biography states consultant scope beyond endorsement.
- NASC membership, cGMP and SQF are manufacturer claims.
What's not in it
- No named lab or public lot COA found.
- Sampled outcome percentages lack methods.
- Manufacturing facility identity and active NASC seal participation are not established.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsEarlier broader-line tier 8 is retained. Current Probiotic groups vitamins and organisms; Allergy lists omega-3 (salmon oil) 9 mg per 4 g chew; Skin Soothe quantifies four active lines per 3.5 g chew.Individual blend amounts remain incomplete. Three current pages do not renew the full-line review.The July/September review described clinical-style outcome percentages without underlying methods or citations and explicitly mapped that evidence to published tier 4, but stored tier 3. The November 14 Probiotic page still displays 87% improved digestion, 91% increased energy and 83% fresher breath without methods or citations beside those claims. This supports tier 4. The earlier cross-product observations retain their original dates.The percentages do not disclose study design, sample size, endpoints or whether they came from surveys or trials. This limitation does not itself establish borrowing of unrelated research.A Pawfy-owned advertorial identifies Dr. Daisy May, DVM, as Vet Consultant for owner education and product-development support. Biography and deeper placement support tier 8.This does not establish each formula’s developer or reviewer; secondary expert-role detail remains limited.Primary product paths show panels, DVM endorsements and quality claims; the consultant biography is on a deeper advertorial route. Tier 8 is retained.No complete primary-navigation expert hub or public named-lab/lot-report route is established.Expert role checked Nov 15; other criterion dates retainedSources: 20 cited source records; individual dates varyIn-depth Pawfy review →39PFYPawfyPawfy Inc.Primary product pages disclose amounts, DVM endorsements and quality claims. Daisy May’s consultant biography is deeper; active NASC seal participation is unverified.
40Rank59.5/100as of 2026-11-14 (C5); other criteria dated 2026-07-03Disclosure Gaps40Rank
Animal Essentials
59.5/100as of 2026-11-14 (C5); other criteria dated 2026-07-03Disclosure GapsAnimal Essentials names an advisory veterinarian and describes its manufacturing program. Three sampled Apawthecary herbal blends use combined amounts; B-Complex separately lists vitamin quantities. Testing is corrected 4→6 for the independently confirmed NASC programme; total 59.5/100, with blend-scope and claim-wording corrections dated November 14.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWorth NotingActive Identity Withheld
The brand uses proprietary blends, grouped amounts, or other label conventions that prevent a buyer from reading the per-active dose on at least one product in the line. Distinct from Line Inconsistency — captures the case where actives are hidden, not where products differ.
What's in it
- A named individual, Dr. Evelyn Kass Williamson, is identified as a Veterinary Advisory Board member with a defined role, reachable from primary navigation.
- The FAQ discloses FDA-registered, GMP-compliant manufacturing and NASC certification, and every checked product page carries a consistent per-ingredient mechanism-level rationale section.
- The UT-Grav FAQ expressly frames the product as urinary support rather than an infection or stone treatment; other detailed passages contain infection-related contexts, so the prior uniformly support-only description is corrected.
What's not in it
- Bos-Curcuma, RespiCalm and UT-Grav give combined herbal-blend totals rather than each herb’s amount. B-Complex separately quantifies vitamins and should not be grouped with these blend-only panels.
- No ingredient-level study, author, or named finished-formula trial was found anywhere on the site.
- NASC independently confirms participation in its audited testing programme, but the reviewed sources do not name a laboratory or provide public lot-linked results.
Why this score— —Why this scoreWhat's missingBrand's own wordsTesting, label/claim wording and flags corrected November 14, 2026; seven criteria dated July 3Sources: 18 dated source records; individual evidence dates retainedFull per-criterion evidence: public dataset ↗In-depth Animal Essentials review →40
Animal EssentialsAnimal Essentials names an advisory veterinarian and describes its manufacturing program. Three sampled Apawthecary herbal blends use combined amounts; B-Complex separately list...Active Identity Withheld
41Rank59/100as of 2026-11-14Disclosure Gaps41Rank
NUPRO Supplements
Nutri-Pet Research, Inc.
Manalapan, NJ, US59/100as of 2026-11-14Disclosure GapsQuantified added ingredients, five-mineral analysis and NASC status; base quantities, named expertise and analytical-report disclosure remain limited.
Public Evidence System Named ExpertsIngredient RationaleDisease-Claim-FreeNASC Audited Listing Clinical Evidence Published Made In USAWorth NotingUndisclosed Base Amounts
Gold/Joint base ingredient amounts are not disclosed. Joint separately quantifies its added actives, including 200 mg Ester-C blend rather than isolated vitamin C.
Unnamed Formulation Expertise
Reviewed sources use anonymous nutrition/veterinary-development framing without a named individual.
What's in it
- Quantitative added-ingredient and electrolyte disclosures
- Ingredient-role explanations and clear scoop/weight guidance
- NASC audited-member confirmation and a lot-code/expiry explanation
What's not in it
- Base whole-food quantities are not disclosed in the reviewed Gold/Joint pages
- No named formulator, study citation or public analytical-report route located in the declared sources
- Broad completeness and detoxification claims lack a directly matched public evidentiary explanation
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsJoint lists glucosamine 500 mg, chondroitin 100 mg, MSM 300 mg and Ester-C blend 200 mg per 1 oz. Electrolyte lists five minerals per 10.3 g.Gold/Joint base ingredient quantities remain undisclosed. Ester-C is blend mass, not isolated vitamin C; calcium min/max make six analysis rows, not six minerals.Gold, Joint and Electrolyte explain recognizable ingredient/nutrient roles and fluid-balance purpose.Some components receive broad benefits, and the detoxification narrative lacks a checkable mechanistic explanation. The score credits disclosed biology, not every claim.Sampled sources use research-developed and scientifically balanced language, but surface no identifiable paper or matching finished-formula trial.This finding is limited to the declared product, ingredient, FAQ and company sources; it does not claim no research exists anywhere.Gold credits an unnamed doctor of nutrition; Joint’s veterinary-development account likewise does not identify the individual.Name, credentials and formula-specific role were not established in the reviewed pages. This does not claim qualified experts never participated.NASC confirms Nutri-Pet Research’s audited participation; its programme requires random independent-lab product testing. Lot codes are not analytical results.Programme records do not name the lab or provide brand-specific results, full panels or individual product/lot coverage.NUPRO describes its NASC quality audit; the council independently lists Nutri-Pet Research. Ingredient pages describe sourcing choices.Actual factory identity/location remains unestablished. New Jersey business address is not factory proof; the limit is missing geography, not a missing second quality logo.Electrolyte use is framed as supplemental/intermittent, and product pages provide dosing guidance.All-essential-nutrient and detoxification claims, including attributing loose stools to toxin removal, lack matched substantiation. This is not a diagnosis or safety conclusion.Main-menu products/ingredients and ordinary footer/company/FAQ routes expose the available quantities and quality information.Quality details are distributed without a consolidated trust hub. Missing disclosures and obsolete guessed URLs are not treated as existing pages being inaccessible.Evidence reviewed Nov 11, 2026Sources: 13 source records; declared sampleIn-depth NUPRO Supplements review →41
NUPRO SupplementsNutri-Pet Research, Inc.Quantified added ingredients, five-mineral analysis and NASC status; base quantities, named expertise and analytical-report disclosure remain limited.Undisclosed Base AmountsUnnamed Formulation Expertise
42Rank58/100as of 2026-07-03Disclosure Gaps42Rank
BIXBI
Boulder, Colorado58/100as of 2026-07-03Disclosure GapsBIXBI publishes detailed food/treat testing and quality-system information, while the sampled supplement lines vary in label detail. Named formulation personnel and supplement-specific laboratory/lot documentation remain unresolved.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWorth NotingUnnamed Experts
The brand uses "veterinarian formulated," "expert designed," or similar language without any publicly named individual, credentials, or role.
What's in it
- Hip-and-joint jerky treats disclose exact per-active doses (Glucosamine 2,400 mg/kg min, Chondroitin Sulfate 1,200 mg/kg min) on the guaranteed-analysis panel.
- The food-safety pages name tested contaminants and pathogens; the dry-food quality-assurance page describes a batch-release testing gate.
- The mushroom-supplement page states NASC Audited Member and USA Made; separate food-manufacturing pages describe facility quality systems.
What's not in it
- No individual formulator, nutritionist, or veterinarian is named anywhere on the public site; only role/credential descriptions are given.
- The reviewed sources do not identify a testing laboratory for the sampled mushroom/functional-jerky supplement lines or provide public supplement lot COAs.
- All four mushroom-supplement SKUs disclose their active mushroom-species blend only as one combined milligram weight, not per-species amounts.
Why this score— —Why this scoreWhat's missingBrand's own wordsTesting text scoped to food/treat versus supplement lines; tier 7 and total 58 retained. Unsupported formal Line Inconsistency flag removed; factual label differences remain.Sources: 26 dated source records; individual evidence dates retainedFull per-criterion evidence: public dataset ↗In-depth BIXBI review →42
BIXBIBIXBI publishes detailed food/treat testing and quality-system information, while the sampled supplement lines vary in label detail. Named formulation personnel and supplement-s...Unnamed Experts
43Rank58/100as of 2026-07-03Disclosure Gaps43Rank
Dr. Harvey's
58/100as of 2026-07-03Disclosure GapsVerified transparency record for Dr. Harvey's. Twelve public sources were fetched and archived on 2026-07-03; every rubric item was checked against the archived HTML, and every exact_quote was confirmed to appear verbatim in its cited source. Absence claims (named experts, facility identity, COA access) were actively probed via the site's XML sitemap and direct URL checks before being confirmed or refuted.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWorth NotingActive Identity Withheld
The brand uses proprietary blends, grouped amounts, or other label conventions that prevent a buyer from reading the per-active dose on at least one product in the line. Distinct from Line Inconsistency — captures the case where actives are hidden, not where products differ.
What's in it
- Manufacturing facility is named at the street, city, and state level (200 Industrial Way West, Eatontown, NJ) with disclosed NASC membership, FDA registration, and cGMP language.
- Two named individuals are connected to the brand: formulation lead Dr. Michael Shen and veterinary endorser Dr. Julia Roach, though neither page states a formal credential.
- Several product label panels, including Coenzyme Q10 and the Allergy + Immune Soft Chews, disclose full per-active milligram amounts rather than a combined blend total.
What's not in it
- The flagship Ortho Flex joint-support supplement discloses its 26 named actives, including Chondroitin Sulfate, as a single 3.3-gram 'proprietary Blend' with no per-active amounts.
- No archived page cites a specific study, author, journal, or clinical trial for any ingredient or finished product.
- No public lot-linked COA lookup or named third-party testing laboratory was found; direct probes of /pages/coa, /pages/quality, and similar handles returned 404.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsVerified against archived product pages fetched 2026-07-03. Disclosure varies sharply by product: the Coenzyme Q10 supplement discloses 'Active Ingredients per Capsule (30 mg): CoEnzyme Q10...30 mg' as a single fully-dosed active, and the Allergy + Immune Soft Chews disclose per-active mg amounts for nine named actives (Colostrum 175 mg, Fish Collagen 150 mg, Turmeric Root 100 mg, and others). However the flagship joint-support supplement, Ortho Flex, discloses its label panel as 'Active Ingredients per Scoop (3.3 grams): A proprietary Blend of Alfalfa, Kelp, Flaxseed, Brewer's Yeast... Turmeric, Chondroitin Sulfate' with 26 named actives combined into a single 3.3-gram total and no individual amounts. The homemade-food base mix carries no dose or Guaranteed Analysis panel at all (different product category; buyer combines with meat at home). This matches tier anchor 6 language most closely: meaningful public dose evidence exists but is scattered across pages and requires a buyer to compare multiple product pages to learn that the brand's own flagship joint supplement is the one using grouped/proprietary-blend labeling rather than the fully-dosed pattern seen elsewhere in the line.The Ortho Flex flagship joint supplement discloses its 26 named actives, including Chondroitin Sulfate (confirmed in the same panel following the quoted excerpt), as a combined 3.3-gram 'proprietary Blend' total with no per-active mg amounts, which prevents a buyer from comparing individual active doses against competing joint products even though other SKUs (CoQ10, Allergy + Immune Soft Chews) in the same line disclose full per-active mg amounts.A proprietary Blend of Alfalfa, Kelp, Flaxseed, Brewer’s Yeast, Lecithin Granules, Spirulina, Garlic, Rose Hips, Red Clover, Devil’s Claw Root, Yucca Root, Skullcap, Sarsaparilla Root, St. John’s Wort, White Willow Bark, Capsicum, Oat Straw, Black Cohosh, Licorice Root, Burdock Root, Ginkgo Biloba Leaf, Nettle LeafVerified against archived pages fetched 2026-07-03, including all seven product label panels and the About Us page. No page states why a specific ingredient was chosen or what biological role it plays for a specific health outcome; the Ortho Flex joint-support label lists 26 named actives, including Turmeric and Chondroitin Sulfate, with no accompanying mechanism text explaining their inclusion beyond the product's category name. The home page's brand-level claim -- 'you and your companion animal benefit from 30+ years of research and experience that has made countless pets live long and happy lives' -- is a general brand-tenure statement, not ingredient-specific rationale, and no page connects it to a specific active. The About Us page states 'Our formulation process is a true team effort, led by Dr. Michael Shen and our dedicated R&D team,' which discloses who leads formulation but not the reasoning behind any specific ingredient's inclusion or dose. This matches tier anchor 4 language: the brand publishes broad benefit and tenure claims with little visible mechanism reasoning, so a buyer cannot evaluate whether any specific ingredient was thoughtfully selected for the product it appears in.No archived page explains the biological role or selection logic for any specific named active (for example, why Chondroitin Sulfate or Turmeric appear in Ortho Flex, or why the Allergy + Immune Soft Chews use a nine-actives blend); the brand discloses who leads formulation but not the reasoning behind ingredient choices.The original Allergy + Immune Soft Chews page describes NASC facility review and random independent testing against label claims. The About page additionally describes an eight-layer quality-control program including ingredient verification, environmental monitoring, metal detection and batch traceability. This facility-level disclosure was already recorded under manufacturing and should not have been omitted from the testing narrative. No named third-party laboratory, lot COA or inspectable lot test result is supplied by the current About page. The existing tier 6 is retained for meaningful but incomplete testing/quality-system detail.The public quality-control program does not identify a third-party laboratory or provide a public lot-linked COA or lot test results in the reviewed material. Guessed-URL 404s are not proof that no testing exists.QC and label-count wording corrected November 14, 2026; numerical assessment July 3Sources: 14 dated source records; individual evidence dates retainedIn-depth Dr. Harvey's review →43
Dr. Harvey'sVerified transparency record for Dr. Harvey's. Twelve public sources were fetched and archived on 2026-07-03; every rubric item was checked against the archived HTML, and every ...Active Identity Withheld- 44RankPNC
PetNC Natural Care
21st Century HealthCare, Inc.
58/100as of 2026-11-14Disclosure GapsPetNC publishes complete sampled dose panels and names Tempe manufacturing with GMP/NASC language. Its parent company also describes an accredited laboratory; the reviewed material does not establish that laboratory’s PetNC assay scope or provide lot results. Testing programme evidence corrected November 14, 2026; other criterion dates retained.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWorth NotingUnnamed Experts
The brand uses "veterinarian formulated," "expert designed," or similar language without any publicly named individual, credentials, or role.
What's in it
- The brand's own product pages disclose a complete active-by-active milligram panel, confirmed consistent across four different product categories.
- The official PetNC page and three independent corroborating sources name the manufacturing facility's city and state (Tempe, AZ) along with GMP compliance and NASC Quality Seal status.
- Marketing language stays within joint-support and quality-of-life framing without disease-treatment claims or unqualified clinical-certainty language.
What's not in it
- No named veterinarian, nutritionist, or product reviewer was found after an active search across 13 public sources.
- The parent company describes an ISO/IEC 17025:2017-accredited laboratory, but the reviewed material does not link its accreditation scope to PetNC assays or provide a PetNC lot-specific COA.
- The brand does not cite any clinical studies or distinguish ingredient-level research from finished-formula evidence anywhere in the reviewed public sources.
Why this score— —Why this scoreWhat's missingBrand's own wordsLaboratory disclosure corrected November 14, 2026; numerical assessment July 3Sources: 16 dated source records; individual evidence dates retainedFull per-criterion evidence: public dataset ↗In-depth PetNC Natural Care review →44PNCPetNC Natural Care21st Century HealthCare, Inc.PetNC publishes complete sampled dose panels and names Tempe manufacturing with GMP/NASC language. Its parent company also describes an accredited laboratory; the reviewed mater...Unnamed Experts
45Rank56.5/100as of 2026-11-15Disclosure Gaps45Rank
Wonder Paws
56.5/100as of 2026-11-15Disclosure GapsNASC-audited programme, a visible named DVM recommendation and a current flagship label; separate advertorial study and specialty claims remain unresolved.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWorth NotingBorrowed Evidence
The brand uses "clinically tested," "clinically proven," "study-backed," or trial-adjacent language without surfacing finished-formula or properly qualified ingredient-level evidence.
What's in it
- A coherent program-level quality stack on a dedicated NASC page: primary-supplier status, completed NASC audit, GMP adherence, FDA-registered USA production — three named quality-system elements together, not just one.
- Current Collagen 3X manufacturer label prints combined collagen 600 mg and hyaluronic acid 5 mg per 2 mL, inactive carriers and 120 mL volume; Chewy lists HA 10 mg, so the source version matters.
- Dr. Paula Simons, DVM is directly visible on the homepage and product page; product and quality information are reachable through ordinary navigation.
What's not in it
- Separate advertorials claim a dermatology specialty and co-design role for Dr. Paula Simons; the reviewed institutional profile confirms DVM, DACVECC but does not establish those additional claims.
- The quoted canine Kim 2018 citation was not verified. The identifiable Nutrients paper concerns humans and cannot substantiate it; the conference-study and 12% absorption claims also lack usable citations in the reviewed sources.
- NASC confirms audited programme participation, including random independent product testing; the reviewed programme records do not publish a named laboratory, analytical panel or lot result. This flagship correction does not establish complete disclosure across the line.
Why this score— —Why this scoreWhat's missingBrand's own wordsLabel, expert and access checked Nov 15, 2026; other criterion dates retainedSources: 26 cited source records; individual dates varyFull per-criterion evidence: public dataset ↗In-depth Wonder Paws review →45
Wonder PawsNASC-audited programme, a visible named DVM recommendation and a current flagship label; separate advertorial study and specialty claims remain unresolved.Borrowed Evidence
46Rank55.5/100as of 2026-07-03Disclosure Gaps46Rank
Dogzymes
Nature's Farmacy
Jasper, Georgia, United States55.5/100as of 2026-07-03Disclosure GapsDogzymes has one of the better label-access paths among small supplement brands, especially for probiotics and its multinutrient flagship, with per-active guaranteed analysis on most SKUs reviewed. Its public footprint still lacks named veterinary or formulation experts, third-party lab testing records, a disclosed manufacturing facility, and study citations, and one product in the line uses an undosed proprietary blend.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWorth NotingUnnamed Experts
The brand uses "veterinarian formulated," "expert designed," or similar language without any publicly named individual, credentials, or role.
What's in it
- Most product pages disclose CFU counts, named microorganisms, and per-active guaranteed analysis with no proprietary blend.
- Official pages explain probiotic, prebiotic, enzyme, and sourcing rationale, including one specific ingredient-selection example (algal oil vs. fish oil).
- The company names its founder and leadership by name with a public origin story, though not as credentialed veterinary or formulation experts.
What's not in it
- No named veterinarian, nutritionist, microbiologist, or credentialed formulation reviewer was found — only a named founder with a non-credentialed, experience-based background.
- No public COA lookup, named lab, lot-specific report, or manufacturing facility disclosure was found.
- One product (Pancreas Support) bundles seven named ingredients into a single undosed proprietary blend line, and evidence pages are reachable only through the footer, not primary navigation.
Why this score— —Why this scoreWhat's missingBrand's own wordsIdentity wording corrected Nov 15, 2026; score Jul 3, 2026Sources: 18 original sources; 1 bounded identity correction sourceFull per-criterion evidence: public dataset ↗In-depth Dogzymes review →46
DogzymesNature's FarmacyDogzymes has one of the better label-access paths among small supplement brands, especially for probiotics and its multinutrient flagship, with per-active guaranteed analysis on...Unnamed Experts
47Rank55/100as of 2026-07-03Disclosure Gaps47Rank
Ark Naturals
55/100as of 2026-07-03Disclosure GapsVerified transparency record for Ark Naturals, current as of the 2026-07-03 research pass. All 8 rubric criteria were re-scored against verbatim quotes from freshly archived source pages, including a sitemap-based check for pages the brand does not link from its own navigation.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWorth NotingUnnamed Experts
The brand uses "veterinarian formulated," "expert designed," or similar language without any publicly named individual, credentials, or role.
What's in it
- Two secondary supplement SKUs (Joint Rescue, Happy Traveler) disclose complete active-by-active mg amounts with weight-tiered feeding directions.
- A dedicated science article, reachable from primary navigation, explains the dental line's antioxidant ingredient with two verifiable PubMed citations and an explicit disease-claim disclaimer.
- USA manufacture and independently confirmed NASC facility-audit/Quality Seal eligibility are disclosed; the manufacturer’s facility identity remains unspecified.
What's not in it
- The clinical plaque/tartar percentage claims still lack a working underlying study report in the reviewed clinical page; Protection+ active amounts are disclosed on the package images.
- No named veterinarian, formulator, or scientific advisor was found anywhere across 16 pages fetched in this pass.
- The NASC programme requires random independent-lab product testing, but the reviewed programme records do not name the lab or provide Ark-specific results, panels or public lot COAs.
Why this score— —Why this scoreWhat's missingBrand's own words47
Ark NaturalsVerified transparency record for Ark Naturals, current as of the 2026-07-03 research pass. All 8 rubric criteria were re-scored against verbatim quotes from freshly archived sou...Unnamed Experts
48Rank54/100as of 2026-11-14 (C5/C6); other criteria dated 2026-07-03Disclosure Gaps48Rank
The Honest Kitchen
The Honest Kitchen
54/100as of 2026-11-14 (C5/C6); other criteria dated 2026-07-03Disclosure GapsThe Why Human Grade page describes supplier COAs and finished-product pathogen testing before release, plus random third-party contaminant screening. Laboratory identity and exact supplement lot documents remain unresolved. Testing corrected 5→6 and manufacturing 7→8 on November 14; six other numerical criteria retain the July 3 assessment.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWorth NotingActive Identity Withheld
The brand uses proprietary blends, grouped amounts, or other label conventions that prevent a buyer from reading the per-active dose on at least one product in the line. Distinct from Line Inconsistency — captures the case where actives are hidden, not where products differ.
What's in it
- Perfect Form names active ingredients per one teaspoon and states there are no inactive ingredients.
- The Why Human Grade page cites current good manufacturing practices and 21 CFR 117 for its human-food-facility standard, and discloses a supplier-level Certificate of Analysis requirement for incoming ingredients. The same page describes finished-product pathogen retesting before release and random third-party contaminant screening.
- The Vet Resources page names one veterinarian, Dr. Leilani Alvarez, DVM, DACVSMR, with a quoted endorsement, and references an independent ISO accredited laboratory used for recipe nutrient testing.
What's not in it
- No public COA lookup or named third-party laboratory was found for Perfect Form or any other supplement/broth batch.
- The formulation team behind The Honest Kitchen's recipes ('leading veterinarians... nutritionists and PhD food scientists') is never named; the one named veterinarian gives a customer-style testimonial, not a formulation or advisory role.
- Perfect Form and two other supplement-line SKUs checked do not disclose individual active amounts, and none has a clinical citation tied to the finished product.
Why this score— —Why this scoreWhat's missingBrand's own wordsTesting/manufacturing corrected November 14, 2026; six criteria dated July 3Sources: 16 dated source records; individual evidence dates retainedFull per-criterion evidence: public dataset ↗In-depth The Honest Kitchen review →48
The Honest KitchenThe Honest KitchenThe Why Human Grade page describes supplier COAs and finished-product pathogen testing before release, plus random third-party contaminant screening. Laboratory identity and exa...Active Identity Withheld
49Rank53.5/100as of 2026-07-03Disclosure Gaps49Rank
Coco and Luna
53.5/100as of 2026-07-03Disclosure GapsNovember 14 correction of label, manufacturing and accessibility criteria using current product galleries and navigation. Twenty-two of 30 formula/format families inspected; five other numerical criteria and their original July 3 evidence dates retained.
Public Evidence System Named ExpertIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWhat's in it
- Quantitative panels are linked in current product galleries across tablets, soft chews and cat powders.
- The homepage identifies Caroline Hood as the named veterinary approver; scope and credentials remain limited.
- The current Mushroom Complex package visibly states USA manufacturing and GMP certification.
What's not in it
- Several formulas retain grouped microorganism, enzyme or mushroom amounts.
- The reviewed clinical-study percentages do not identify the supporting study or methods.
- The reviewed sources do not name a testing laboratory or link a lot-specific COA.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsCurrent linked gallery panels were inspected for 22 of 30 distinct formula/format families after ten multipacks were excluded. Sixteen of the 30 families disclose individual active/preparation quantities. Six other inspected families include grouped microbial, enzyme or mushroom amounts. The original four sampled families all have quantitative panels: Omega-3 tablets, Skin & Coat soft chews, cat Daily powder and dog 10-in-1 tablets. The earlier no-amount premise is contradicted by the panels.Dog Probiotics soft chews disclose a 50 mg proprietary microbial blend; Probiotics tablets give a 150 mg enzyme blend and pooled 5.5 billion CFU; Mushroom Complex tablets give a 600 mg six-mushroom blend. Other pooled microbial/enzymatic rows also remain. Individual component amounts are not disclosed for those grouped rows; eight current families were outside this label-only inspection.The current Mushroom Complex soft-chew package image states manufactured in the USA and displays a GMP-certified badge. It identifies Vita Pet Life LLC at a Miramar, Florida address as the business the product is manufactured for. That business address does not establish the factory identity. The quality claim is visible in the product gallery, rather than available only through raw product data.USA location and GMP certification are manufacturer claims on the package. The actual manufacturing facility and certification scope are not identified by the manufactured-for business address.The homepage names Caroline Hood in its expert module and links the Immune Health collection in primary navigation. That collection links the Mushroom Complex PDP, whose gallery includes the inspected manufacturing and Product Facts package image. Other quantitative panels are linked in their corresponding product galleries. Published details are reachable through ordinary navigation, though quality information is distributed among products rather than consolidated in one trust hub.Manufacturing detail requires the relevant product gallery rather than a consolidated trust page. Current study methods, a testing report and the named expert’s detailed credentials were not established by this bounded inspection; those evidence questions retain their separate original criteria.C1/C6/C8 corrected November 14, 2026; five other criteria dated July 3Sources: 37 dated source records; individual evidence dates retainedIn-depth Coco and Luna review →49
Coco and LunaNovember 14 correction of label, manufacturing and accessibility criteria using current product galleries and navigation. Twenty-two of 30 formula/format families inspected; fiv...
50Rank53/100as of 2026-07-03Disclosure Gaps50Rank
kin+kind
53/100as of 2026-07-03Disclosure GapsVerified transparency record for kin+kind following a hostile adversarial pass completed 2026-07-03. All 15 sources were fetched and archived; every rubric criterion's exact_quote was checked verbatim against the archived HTML, with 2 of 8 quotes replaced after the originals were found to be non-evidentiary UI-chrome text. Every absence claim (named veterinarian, facility-level quality certification, COA lookup) was actively probed via sitemap enumeration and direct URL testing before being confirmed. All 8 criteria are marked verified with score_status locked and anchor language cited in the evidence text.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWorth NotingActive Identity Withheld
The brand uses proprietary blends, grouped amounts, or other label conventions that prevent a buyer from reading the per-active dose on at least one product in the line. Distinct from Line Inconsistency — captures the case where actives are hidden, not where products differ.
Unnamed Experts
The brand uses "veterinarian formulated," "expert designed," or similar language without any publicly named individual, credentials, or role.
What's in it
- The Flea+Tick spray line publishes a full active-ingredient percentage panel directly on the product page (e.g., Peppermint Oil 1.00%, Rosemary Oil 1.00%, Cedarwood Oil 0.20%).
- A real facility location (New Jersey) is disclosed for its US manufacturing, and the Hip+Joint supplement's curcumin-bioavailability claims link two live, publicly-accessible NCBI/PubMed articles as ingredient-level research.
- Evidence pages for ingredients, manufacturing, and the vet-formulated claim are reachable in one click from a primary-header dropdown menu on every page of the site.
What's not in it
- The veterinarian behind the brand's repeated 'vet formulated' and 'designed by our own veterinarian' claims is never named or credentialed anywhere in the site's public footprint, including on a page built specifically around that claim.
- No third-party testing laboratory, certificate-of-analysis lookup, or contaminant/microbial/potency panel is disclosed anywhere on the site; direct probes of common transparency-page handles (COA, lab-results, quality-assurance, testing) all returned HTTP 404.
- The Flea+Tick line's above-the-fold 'CLINICALLY PROVEN FLEA & TICK REPELLENCY... Tested to deliver over 90% efficacy' claim has no visible study, author, or citation anywhere it appears, despite the brand showing real citation discipline for its supplement line.
Why this score— —Why this scoreWhat's missingBrand's own wordsFacility/flag correction November 14, 2026; numerical assessment July 3Sources: 16 dated source records; individual evidence dates retainedFull per-criterion evidence: public dataset ↗In-depth kin+kind review →50
kin+kindVerified transparency record for kin+kind following a hostile adversarial pass completed 2026-07-03. All 15 sources were fetched and archived; every rubric criterion's exact_quo...Active Identity WithheldUnnamed Experts
La Petite Labs — publisher benchmark
82.5/100 under the published rubric.
Substantial public ingredient, research, expert and testing disclosure, with gaps in lipid detail, lot coverage and consistency of claims.
Criterion scores and reasons
| Criterion | Score | Weight | Evidence and limits |
|---|---|---|---|
| label dose transparency | 8/10 | 15 | Both underlying formulas publish individual quantities and serving sizes:17 active lines for Hollywood Elixir and 13 for Pet Gala. Pet Gala also markets the omega 3, 6 and 9 components separately while giving their combined 150 mg amount. The omega mixture is a meaningful skin/barrier component, not a minor secondary ambiguity; individual fatty-acid amounts and source remain unspecified. This meets most-products disclosure at 8 rather than complete-line 9/10. |
| scientific rationale disclosure | 9/10 | 10 | Both products have ingredient-to-role groups, research landing pages and linked species-specific frameworks covering NAD metabolism, mitochondrial cofactors, antioxidant and immune roles, structural proteins, barrier lipids, hydration and keratin nutrients. Some secondary ingredients and broad organ-support descriptions have less specific mechanism explanation. A single consolidated hub is not required by this criterion. |
| evidence clinical citation transparency | 8/10 | 15 | The two research pages identify and link published studies and provide author/study context, with deeper evidence-framework links. The public product evidence is primarily ingredient, mechanistic and related-formula evidence. Prominent study cards sit beside finished-product rationale without equally explicit formula non-equivalence; the dog combination trial, feline diet trial and EPA/DHA trial cannot be described as tests of the LPL formulas. Missing finished-formula RCT s alone do not lower this criterion. |
| veterinary expert transparency | 9/10 | 15 | Several named veterinarians have credentials, educational roles and biographies surfaced on the expert page, including Jo Anna Pendergrass and Sarah Calvin. Secondary contributor cards state less precise scope. Do not equate an educational contributor with the formulator of every product. The rubric does not require a named owner for every formula to earn 9. |
| testing coa transparency | 8/10 | 15 | The brand names independent laboratory channels and publishes a lot-specific manufacturer COA for Hollywood Elixir 2604066 reporting microbial and heavy-metal results. The certificate also discloses its ingredient-input verification method. Pet Gala has no published lot record in the current lookup; HE formula rows are record/component-substantiated, not quantitative finished-product potency assays. Named third-party program disclosure earns 8; a manufacturer summary is not proof of complete independent lab coverage. |
| manufacturing quality system transparency | 8/10 | 10 | The current shared product quality disclosure names USA, c GMP compliance and a NASC Preferred Supplier facility. NutraSky, LLC is identified as the manufacturer quality-unit issuer of the HE lot certificate. The public material does not identify the manufacturing facility by name, city and state with complete certification scope; the company name on a certificate does not establish that entire facility-level record. NASC Preferred Supplier is not an LPL product approval. |
| claim discipline consumer honesty | 7/10 | 10 | Current product descriptions generally use wellness-support language and advise veterinary consultation. Some modules expressly state that products complement complete meals and veterinary care. The wider public presentation still includes complete-system framing, promised more stable or longer-lasting results, and more-years/life-ahead wording without corresponding finished-formula outcome evidence. The mixed pattern fits 7, rather than an isolated minor wording issue. |
| accessibility buyer verifiability | 9/10 | 10 | The captured primary header exposes expert and product routes and a COA link; product/research/expert pages connect ingredient evidence, testing and the internal standard. Buyers can inspect the underlying material through multiple public paths. Evidence remains distributed across several destinations rather than one comprehensive trust hub. The current menu API was inaccessible to this reviewer, so no new live navigation-performance claim is made. |
Sources reviewed through 11 November 2026.
Hollywood Elixir current product and linked public support fields; Pet Gala current product and linked public support fields; Pampered System current product and linked support fields; Hollywood Elixir ingredient disclosure; Pet Gala ingredient disclosure; Hollywood Elixir research landing page; Pet Gala research landing page; Named veterinary contributors; LPL-01 standard; Public lot lookup and laboratory disclosures; NutraSky manufacturer COA for Hollywood Elixir lot 2604066; Pampered explanation page; Primary navigation source
How the scores were calculated
Each criterion is assigned against the published rubric and supported by dated sources. The total is the sum of each score divided by ten and multiplied by its weight. Source selection and tier assignment require editorial judgment. The same definitions apply to the publisher benchmark, which remains outside the competitive ranking.
Ingredient or pathway coverage describes this rubric’s selected categories; it does not establish a clinical advantage. Nutrient analysis and ingredient input weight are different disclosures. Facility auditing, analytical testing and public batch reports also answer different questions.
Corrections
Material factual errors are reviewed when identified. Please identify the exact statement and supporting source. Corrections are applied to the affected assessment, FAQs, summaries, structured data and downloadable dataset together. Additional reliable evidence may change an assessment.
Evidence dataset
Nov 15, 2026: Plano Paws label/accessibility and Pawfy expert-role corrections; other criterion dates retained.
Continue exploring
Common questions
What changed in this reassessment?
November 15, 2026: Plano Paws label and accessibility tiers corrected to 8/8, total 34→45; Pawfy named-expert tier corrected to 8, total 60.5→62. Pawfy’s manufacturer membership statement is retained while active NASC Quality Seal participation is unverified. Other numerical tiers and their individual evidence dates are retained.
What do these scores measure?
The published disclosure and formulation criteria. They do not establish comparative safety, clinical effectiveness or suitability for an individual animal.
Does a missing public batch report mean no testing occurs?
No. A public batch report, an analytical testing program and a facility audit are different forms of evidence.
Can additional evidence change a score?
Yes. We review specific, supported factual corrections and apply the published criterion definitions to the corrected evidence.
Breadth, disclosure, and substantiation.
- Coverage of multiple longevity pathways under one daily formula.
- Per-active milligram amounts disclosed on the public label.
- Named third-party lab, published Certificate of Analysis, lot-level traceability.
- Public substantiation for marketing claims — citations, not adjectives.
Narrower scope, or less of the work published.
- The product targets a single problem rather than longevity-system coverage.
- Actives are listed without per-serving amounts (proprietary blends).
- Testing language is vague — no named lab, no public COA, no lot linkage.
- Claims outrun the public evidence record at time of review.
A lower score does not automatically mean a product is unsuitable. It may simply be narrower in scope, less transparent, or supported by fewer public quality signals than this rubric rewards.
51Rank52.5/100as of 2026-11-15Disclosure Gaps51Rank
Solid Gold
52.5/100as of 2026-11-15Disclosure GapsRationale corrected 5→6; total 52.5/100, for accessible ingredient mechanisms in the FAQ. The current twelve-product range extends beyond SeaMeal, and both Multivitamin and Mobility publish amounts, though Mobility groups components. Food-specific positive release and NASC membership are not presented as audited supplement testing.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Quality Seal Finished-Formula Trial Named Mfg FacilityWorth NotingActive Identity Withheld
The brand uses proprietary blends, grouped amounts, or other label conventions that prevent a buyer from reading the per-active dose on at least one product in the line. Distinct from Line Inconsistency — captures the case where actives are hidden, not where products differ.
Unnamed Experts
The brand uses "veterinarian formulated," "expert designed," or similar language without any publicly named individual, credentials, or role.
What's in it
- SeaMeal provides quantified guaranteed analyses; Multivitamin Chews additionally publishes individual vitamin amounts and 250 million CFU per 1.8 g chew.
- Supplement pages disclose USA manufacture with US and global ingredients; NASC independently confirms membership, distinct from audited Quality Seal permission.
- Marketing language avoids disease-treatment or guaranteed-outcome claims, and the brand proactively and transparently addresses the FDA DCM investigation rather than staying silent on it.
What's not in it
- No named veterinarian, nutritionist, or formulator was found anywhere on the reviewed pages -- only anonymous 'vet survey' and 'team of scientists' language.
- Mobility Chews gives 475 mg and 120 mg proprietary totals rather than individual components. The reviewed supplement sources do not publish a lot-linked COA or name a testing laboratory.
- Recurring unqualified 'transformational' outcome language appears in the brand's own meta description and its Amazon manufacturer content without a supporting citation.
Why this score— —Why this scoreWhat's missingBrand's own wordsRationale/label correction Nov 15, 2026; seven numerical criteria dated July 3Sources: 20 dated source records; individual evidence dates retainedFull per-criterion evidence: public dataset ↗In-depth Solid Gold review →51
Solid GoldRationale corrected 5→6; total 52.5/100, for accessible ingredient mechanisms in the FAQ. The current twelve-product range extends beyond SeaMeal, and both Multivitamin and Mobi...Active Identity WithheldUnnamed Experts- 52RankSL
STRELLALAB
StrellaLab LLC
Sheridan, WY49.5/100as of 2026-11-15Sparse Public EvidenceExpert disclosure corrected 4→5 for the named endorsement; total 49.5/100. The current Advanced panel includes chondroitin 60 mg per three chews. Other sampled labels remain incomplete or inconsistent. NASC membership is credited without claiming completed audit; no named testing laboratory or lot report is supplied in the reviewed materials.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Quality Seal Finished-Formula Trial Named Mfg FacilityWorth NotingActive Identity Withheld
The brand uses proprietary blends, grouped amounts, or other label conventions that prevent a buyer from reading the per-active dose on at least one product in the line. Distinct from Line Inconsistency — captures the case where actives are hidden, not where products differ.
What's in it
- The Advanced Glucosamine large/senior gallery lists individual amounts per three chews, including chondroitin sulfate 60 mg.
- The panel states Made in USA, FDA-registered facility and GMP certified. NASC supplier membership is independently confirmed, separate from audited Quality Seal permission.
- Official pages show company contact information, a full company address, and clear supplement categories.
What's not in it
- The named “DR. EVELYN VANDER, DV” endorsement has no biography, full qualification or formulation role.
- No public COA lookup, named laboratory, or lot-level test report was found, and the brand's own NASC membership signal is not linked anywhere on its own website.
- The joint page’s hemp-based text and large/senior gallery are different formulations; omega amount basis and probiotic CFU/mg remain unclear or absent in the sampled materials.
Why this score— —Why this scoreWhat's missingBrand's own wordsExpert/label correction Nov 15, 2026; seven numerical criteria dated July 3Sources: 21 dated source records; individual evidence dates retainedFull per-criterion evidence: public dataset ↗In-depth STRELLALAB review →52SLSTRELLALABStrellaLab LLCExpert disclosure corrected 4→5 for the named endorsement; total 49.5/100. The current Advanced panel includes chondroitin 60 mg per three chews. Other sampled labels remain inc...Active Identity Withheld
53Rank46.5/100as of 2026-11-14 (C4); C6 mapping corrected using 2026-07-03 evidenceSparse Public Evidence53Rank
Under the Weather Pet
46.5/100as of 2026-11-14 (C4); C6 mapping corrected using 2026-07-03 evidenceSparse Public EvidenceUnder the Weather publishes per-active chew panels, Vermont manufacturing disclosure and a named DVM/MS endorsement. Expert and manufacturing tiers were corrected November 14; six other criterion values and the manufacturing factual evidence retain the July 3 assessment.
Public Evidence System Named DVM EndorserIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWorth NotingUnnamed Experts
The brand uses "veterinarian formulated," "expert designed," or similar language without any publicly named individual, credentials, or role.
What's in it
- Real per-active panels on both calming-chew SKUs (cat: thiamine 65 mg, L-tryptophan 10 mg, L-theanine 8.5 mg; dog: ginger 60 mg, chamomile 50 mg, L-theanine 20 mg, L-tryptophan 20 mg per serving).
- Specific sourcing disclosure: 100% USA human-grade meats — cage-free poultry, grass-fed beef, wild line-caught salmon — plus a repeated, consistent Vermont manufacturing location across five live pages.
- Honest vet-routing habits in the FAQ, including a candid "we are not veterinarians" and pregnancy/nursing cautions.
- Dr. Vijay Sasi, DVM, MS, is named in a public homepage endorsement, present in both the July 3 capture and current source.
What's not in it
- The FAQ claims the products 'have no harmful side effects' — an absolute safety claim no supplement can carry.
- The July 3 hero's 'Calms in ~30 min' claim had no linked study basis in that review; the Ready Cal product page named three veterinary journals without author, year or link.
- The July 3 review did not locate lab, COA, lot or panel artifacts or a facility name/city/quality-system certification beyond Vermont. The named endorsement does not identify each product’s formulator.
Why this score— —Why this scoreWhat's missingBrand's own wordsC6 mapping 6→7 for repeated Vermont manufacture; total 45.5→46.5. Manufacturing factual evidence remains dated July 3; prior C4 correction retained.Sources: 11 dated source records; individual evidence dates retainedFull per-criterion evidence: public dataset ↗In-depth Under the Weather Pet review →53
Under the Weather PetUnder the Weather publishes per-active chew panels, Vermont manufacturing disclosure and a named DVM/MS endorsement. Expert and manufacturing tiers were corrected November 14; s...Unnamed Experts
54Rank45/100as of 2026-11-15Sparse Public Evidence54Rank
Plano Paws
45/100as of 2026-11-15Sparse Public EvidenceSix of nine sampled families quantify major active inputs. Vita/Tummy blends and the liquid panel remain gaps. Primary navigation exposes quality statements.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWhat's in it
- USA/GMP/FDA-inspection and independent-testing statements.
- Quantitative panels across multiple chew and softgel families.
- Softgel label lists anchovy/sardine oils and EPA/DHA amounts.
What's not in it
- No named expert found in reviewed sources.
- No named lab or public lot COA found.
- Vita/Tummy grouped components and sampled liquid-dose gap; outcome claims lack linked product evidence.
Why this scoreitap any criterion for evidence— —Why this scoreWhat's missingBrand's own wordsCurrent manufacturer galleries quantify individual major-active inputs in six of nine reviewed formula/format families. Vita Treats and Tummy Treats retain grouped amounts; the sampled liquid page has no quantitative panel. This supports tier 8.Individual blend components remain unquantified. The softgel label and page prose name different fish; source versions are kept separate.Primary navigation links the quality page; shop routes expose quantitative gallery panels. Tier 8 evaluates access to the evidence the brand publishes.No comprehensive evidence hub. Named-lab, lot and expert gaps remain under their substantive criteria.Label/access checked Nov 15; other criterion dates retainedSources: 28 cited source records; individual dates varyIn-depth Plano Paws review →54
Plano PawsSix of nine sampled families quantify major active inputs. Vita/Tummy blends and the liquid panel remain gaps. Primary navigation exposes quality statements.
55Rank43/100as of 2026-11-14 (C4/C5); C6 mapping corrected using 2026-07-03 evidenceSparse Public Evidence55Rank
PetAlive
Silver Star Brands, Inc., doing business as Native Remedies
Oshkosh, WI, U.S.A.43/100as of 2026-11-14 (C4/C5); C6 mapping corrected using 2026-07-03 evidenceSparse Public EvidencePetAlive states USA manufacture with FDA registration and cGMP, unnamed veterinary formulation and third-party purity/potency testing. The corrected tiers are manufacturing 8, experts 4 and testing 4; five other numerical tiers retain the July 3 assessment. Indexed-source and direct 403 provenance remains recorded.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWorth NotingActive Identity Withheld
The brand uses proprietary blends, grouped amounts, or other label conventions that prevent a buyer from reading the per-active dose on at least one product in the line. Distinct from Line Inconsistency — captures the case where actives are hidden, not where products differ.
Unnamed Experts
The brand uses "veterinarian formulated," "expert designed," or similar language without any publicly named individual, credentials, or role.
What's in it
- Plainly stated manufacturing stack: USA manufacture in FDA-registered facilities with cGMP compliance and a described Full Spectrum extraction process.
- A genuinely built service layer: free Ask Our Experts (24–48h answers), a product finder, and an ailment index, all reachable from the hub.
- Category conventions are followed honestly on the homeopathic side (dilution-and-format presentation).
- The Adrenal Support listing states formulation by a veterinary/natural-remedy team and third-party purity/potency testing.
What's not in it
- The FAQ claims homeopathic medicines carry 'no risk of side effects or known interactions with pharmaceutical drugs' — a double absolute presented as fact.
- Veterinary formulation is claimed, but the reviewed listing does not identify individual veterinarians, their credentials or product responsibilities.
- The reviewed listing does not identify the testing laboratory, publish a lot COA or quantify the individual herbal ingredients.
Why this score— —Why this scoreWhat's missingBrand's own wordsC6 mapping 7→8 for existing USA/FDA-registered/cGMP disclosure; total 42→43. Manufacturing factual evidence remains dated July 3; prior C4/C5 corrections retained.Sources: 7 dated source records; individual evidence dates retainedFull per-criterion evidence: public dataset ↗In-depth PetAlive review →55
PetAliveSilver Star Brands, Inc., doing business as Native RemediesPetAlive states USA manufacture with FDA registration and cGMP, unnamed veterinary formulation and third-party purity/potency testing. The corrected tiers are manufacturing 8, e...Active Identity WithheldUnnamed Experts- 56RankAN
Amazing Nutritionals
Amazing Fair
Los Angeles, CA area41.5/100as of 2026-07-03Sparse Public EvidenceAmazing Nutritionals is more accessible and more quantitatively labeled than a first pass suggested — most SKUs disclose per-active mg amounts and the brand names a state-level GMP facility reachable from the home-page footer. But its own marketing copy names specific diagnosable conditions as claim targets across most of the line without any clinical citation, and no named expert or public lab report was found anywhere on the site.
Public Evidence System Named Vet ReviewerIngredient RationaleDisease-Claim-FreeNASC Member Finished-Formula Trial Named Mfg FacilityWorth NotingActive Identity Withheld
The brand uses proprietary blends, grouped amounts, or other label conventions that prevent a buyer from reading the per-active dose on at least one product in the line. Distinct from Line Inconsistency — captures the case where actives are hidden, not where products differ.
Unnamed Experts
The brand uses "veterinarian formulated," "expert designed," or similar language without any publicly named individual, credentials, or role.
What's in it
- Turmeric, cranberry, and omega-3 product pages disclose per-active mg amounts for every named ingredient, with no proprietary blend on those three SKUs.
- The brand names a GMP and Organic-Certified manufacturing facility at the state level (Florida) and describes a batch-level testing process, both reachable within one click from the home-page footer.
- Testing and manufacturing evidence is publicly footer-linked (FAQ, Why Buy) rather than requiring a support request.
What's not in it
- No named veterinarian, nutritionist, or formulator was found anywhere on the site; a repeated 'veterinary science approved' phrase names no individual.
- No third-party laboratory, public certificate of analysis, or lot-level lookup was found for any product.
- Marketing language names diagnosable conditions (rheumatoid arthritis, staph infection, urinary tract infection) as prevent/eliminate/remedy targets across most of the product line, paired with an unqualified 'Guaranteed results, or your money back!' claim.
Why this score— —Why this scoreWhat's missingBrand's own wordsTesting description corrected November 14, 2026; numerical assessment July 3, 2026Sources: 14 dated source records; individual evidence dates retainedFull per-criterion evidence: public dataset ↗In-depth Amazing Nutritionals review →56ANAmazing NutritionalsAmazing FairAmazing Nutritionals is more accessible and more quantitatively labeled than a first pass suggested — most SKUs disclose per-active mg amounts and the brand names a state-level ...Active Identity WithheldUnnamed Experts





